data_1ssf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ssf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.591 ' CD2' ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.591 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 64' ' ' ASP . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 68' ' ' THR 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.662 ' CE1' ' HH ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.877 0.846 . . . . 0.0 112.936 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.662 ' HH ' ' CE1' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.543 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' H ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HB3' HD22 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' SG ' ' A' ' 58' ' ' CYS 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.525 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CE2' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 1.2 p80 . . . . . 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 . . . . . 0 CA--C 1.504 -0.792 0 CA-C-O 121.681 0.753 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 HD12 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.478 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.525 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 15' ' ' VAL 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.8 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CG2' HG12 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' CZ ' ' HG ' ' A' ' 57' ' ' LEU . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HZ1' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.435 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG22 ' HD2' ' A' ' 62' ' ' PRO 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 61' ' ' ILE . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.564 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 111.78 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 103' ' ' TRP . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 94' ' ' SER . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HZ2' ' HB3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.457 HD11 HD12 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 56' ' ' LEU . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.425 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' HD22 ' A' ' 111' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' CD ' HG22 ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 84' ' ' HIS 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.448 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.521 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 . . . . . 0 CA--C 1.499 -0.988 0 CA-C-O 123.6 1.667 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.514 HE22 ' CD ' ' A' ' 102' ' ' LYS . 1.1 pp0? -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.514 ' CD ' HE22 ' A' ' 100' ' ' GLN . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.524 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' CG ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG12 ' CG1' ' A' ' 14' ' ' VAL . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 56' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.489 HD22 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 64' ' ' ASP 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 62' ' ' PRO . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' HB2' ' HZ1' ' A' ' 97' ' ' LYS . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.684 ' CD2' ' HH ' ' A' ' 93' ' ' TYR . 8.6 p80 . . . . . 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 122.536 1.16 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.684 ' HH ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HZ1' ' HB2' ' A' ' 69' ' ' ALA . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 24' ' ' PHE . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.282 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG1' HG12 ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 14' ' ' VAL . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' HH ' ' CD1' ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' CD1' ' HH ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.483 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.428 ' CD1' ' HA2' ' A' ' 116' ' ' GLY 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 64' ' ' ASP . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.521 HG22 ' HH ' ' A' ' 93' ' ' TYR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.536 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 . . . . . 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' HH ' HG22 ' A' ' 81' ' ' VAL . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.536 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.455 ' CG ' ' HB1' ' A' ' 108' ' ' ALA . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' HB2' ' A' ' 123' ' ' TYR . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.423 ' HB2' ' HG ' ' A' ' 119' ' ' LEU . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.47 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo . . . . . 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' CG2' ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.412 ' N ' HG21 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD11 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 62' ' ' PRO 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.433 ' HD2' HG22 ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 63' ' ' LEU 0.341 2.3 p80 . . . . . 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 . . . . . 0 CA--C 1.494 -1.186 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.511 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.48 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.685 HD21 ' H ' ' A' ' 13' ' ' ARG 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.685 ' H ' HD21 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG12 ' HZ3' ' A' ' 17' ' ' LYS . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.569 ' HE3' ' CE2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 16' ' ' ALA 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 59' ' ' ASP 0.304 0.8 OUTLIER . . . . . 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 . . . . . 0 CA--C 1.501 -0.941 0 CA-C-O 121.647 0.737 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.511 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 29' ' ' ILE 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' ASP . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 . . . . . 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.498 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.403 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 7.1 m120 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.402 HD11 ' HD2' ' A' ' 62' ' ' PRO . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' LEU . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 125' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 HG22 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.453 ' N ' HG21 ' A' ' 33' ' ' VAL . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' HG ' ' CZ ' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' HD22 ' A' ' 111' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 99' ' ' GLY . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 97' ' ' LYS . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 104' ' ' TYR . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.477 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.564 HE22 ' HA ' ' A' ' 67' ' ' VAL . 24.8 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HA ' HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 m -162.77 -116.37 0.01 OUTLIER 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.892 -1.13 . . . . 0.0 113.628 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 12' ' ' LEU 0.253 42.0 p90 -114.28 40.82 2.42 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.234 1.413 . . . . 0.0 110.913 -175.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.302 2.8 m -76.26 5.97 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 174.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.34 31.08 2.46 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 128.408 2.908 . . . . 0.0 110.08 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.591 ' CD2' ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.591 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HB2' ' CG2' ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.428 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 64' ' ' ASP . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 68' ' ' THR 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -137.37 168.05 20.4 Favored 'General case' 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.7 pm0 -38.4 159.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 1 N-CA-C 122.489 4.255 . . . . 0.0 122.489 -173.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.67 -50.48 63.17 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -167.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -110.48 -4.95 15.27 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.326 1.051 . . . . 0.0 109.698 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -118.88 6.12 11.43 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -161.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER -54.97 153.25 6.53 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 128.659 2.784 . . . . 0.0 118.132 174.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.662 ' CE1' ' HH ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -145.53 158.85 43.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.52 162.01 41.79 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.741 -173.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -138.05 129.06 27.19 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 166.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 31.6 tt0 -106.46 160.44 15.4 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.491 2.316 . . . . 0.0 106.789 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -65.76 66.11 0.04 OUTLIER 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.747 2.019 . . . . 0.0 116.228 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.95 14.16 8.06 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 127.59 2.519 . . . . 0.0 113.295 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 33.4 tt0 -140.68 139.79 34.84 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.06 132.05 41.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.772 -1.83 . . . . 0.0 108.777 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 -143.93 128.22 17.79 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 116.279 -2.169 . . . . 0.0 112.936 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.662 ' HH ' ' CE1' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.11 -24.51 3.86 Favored 'Trans proline' 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -118.39 158.28 25.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.779 3.232 . . . . 0.0 109.087 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 C--N 1.358 0.961 0 C-N-CA 126.078 1.751 . . . . 0.0 112.262 178.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.8 m -81.33 71.23 8.31 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.322 1.849 . . . . 0.0 113.858 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . 0.583 0.9 OUTLIER 78.05 -8.82 1.61 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 129.387 3.075 . . . . 0.0 117.113 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.286 1.6 m -67.26 5.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 118.884 2.92 . . . . 0.0 118.884 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.39 25.08 7.09 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 129.158 3.266 . . . . 0.0 111.796 170.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' H ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HB3' HD22 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' SG ' ' A' ' 58' ' ' CYS 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 119' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.525 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -137.76 169.18 18.24 Favored 'General case' 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -38.09 144.05 0.11 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -43.42 -50.03 6.98 Favored 'General case' 0 C--N 1.361 1.083 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.37 0.8 16.75 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 121.319 1.872 . . . . 0.0 110.59 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -119.81 9.78 11.43 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 120.527 -1.358 . . . . 0.0 113.727 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CE2' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -55.09 162.72 1.25 Allowed 'General case' 0 C--N 1.352 0.679 1 C-N-CA 132.796 4.438 . . . . 0.0 116.322 172.426 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 1.2 p80 -144.64 152.43 40.46 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 146.2 47.2 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -138.2 128.51 26.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 167.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -123.34 161.18 25.18 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.811 2.044 . . . . 0.0 106.307 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 p -61.3 76.15 0.01 OUTLIER 'General case' 0 C--N 1.359 1.011 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.29 2.72 31.3 Favored Glycine 0 C--N 1.359 1.81 0 C-N-CA 127.367 2.413 . . . . 0.0 113.779 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -128.55 111.86 13.7 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.82 119.4 35.88 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 117.145 -1.407 . . . . 0.0 107.745 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 -144.68 127.31 16.12 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 113.985 -3.086 . . . . 0.0 111.154 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 HD12 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.478 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.525 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 15' ' ' VAL 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.76 -11.11 12.77 Favored 'Trans proline' 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -113.84 118.96 35.69 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.678 2.391 . . . . 0.0 104.806 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.356 0.852 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.8 t30 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -67.95 41.62 0.03 OUTLIER 'General case' 0 C--N 1.358 0.957 1 C-N-CA 131.873 4.069 . . . . 0.0 117.598 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -113.21 -61.94 1.66 Allowed 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 127.331 2.252 . . . . 0.0 105.195 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.41 27.2 m -60.45 6.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.83 22.57 16.26 Favored Glycine 0 C--N 1.351 1.416 1 C-N-CA 132.741 4.972 . . . . 0.0 110.878 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CG2' HG12 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' CZ ' ' HG ' ' A' ' 57' ' ' LEU . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HZ1' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.435 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG22 ' HD2' ' A' ' 62' ' ' PRO 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 61' ' ' ILE . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m -139.02 167.45 22.02 Favored 'General case' 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.79 169.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.22 -46.19 34.93 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 120.796 3.628 . . . . 0.0 120.796 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.86 9.46 24.59 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.147 1.779 . . . . 0.0 110.613 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.88 -33.24 3.8 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 120.413 -1.429 . . . . 0.0 112.813 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.61 141.02 27.08 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.564 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -140.74 149.86 42.68 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -130.13 162.13 29.53 Favored 'General case' 0 C--N 1.37 1.459 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.63 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -137.81 139.96 40.27 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 158.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 29.9 tt0 -116.41 161.19 19.45 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.016 2.127 . . . . 0.0 106.34 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 65.01 0.01 OUTLIER 'General case' 0 C--N 1.365 1.254 0 C-N-CA 127.114 2.166 . . . . 0.0 115.729 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.89 8.04 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 127.697 2.57 . . . . 0.0 112.992 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 34.8 tt0 -140.49 142.92 35.25 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.57 131.96 40.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 O-C-N 119.754 -1.842 . . . . 0.0 108.151 -172.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.36 138.44 27.81 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 115.037 -2.665 . . . . 0.0 111.78 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 103' ' ' TRP . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 94' ' ' SER . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.457 HD11 HD12 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 56' ' ' LEU . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -95.65 33.45 0.16 Allowed 'Trans proline' 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -116.09 132.68 56.59 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 120.625 1.557 . . . . 0.0 112.428 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--N 1.352 0.703 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.237 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -135.57 8.96 3.37 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.079 1.752 . . . . 0.0 109.601 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 6.9 p90 -121.79 32.67 5.77 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.869 1.668 . . . . 0.0 111.008 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.401 1.5 m -72.97 6.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.71 26.73 3.14 Favored Glycine 0 C--N 1.358 1.8 0 C-N-CA 128.606 3.003 . . . . 0.0 111.237 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HB2' HG21 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' HD22 ' A' ' 111' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' CD ' HG22 ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 84' ' ' HIS 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m -137.48 168.84 18.85 Favored 'General case' 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.6 pm0 -37.73 156.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -48.67 -51.14 29.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 120.557 3.54 . . . . 0.0 120.557 -164.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -110.75 -8.68 14.54 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.909 1.284 . . . . 0.0 109.544 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.16 4.68 21.29 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -163.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.13 158.67 2.83 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 129.201 3.0 . . . . 0.0 118.496 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -138.07 149.28 45.84 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 161.87 36.88 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.14 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.27 24.9 pttm -137.68 148.4 45.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.919 161.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 3.6 tm-20 -117.96 161.41 19.83 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 128.41 2.684 . . . . 0.0 106.026 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -59.03 64.83 0.0 OUTLIER 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.495 2.318 . . . . 0.0 116.908 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.13 13.85 8.14 Favored Glycine 0 C--N 1.356 1.651 0 C-N-CA 127.397 2.427 . . . . 0.0 112.741 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 76.2 tt0 -139.9 147.84 41.17 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.38 129.63 37.67 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 -145.72 136.23 24.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 123.456 2.844 . . . . 0.0 112.228 169.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.514 HE22 ' CD ' ' A' ' 102' ' ' LYS . 1.1 pp0? -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.514 ' CD ' HE22 ' A' ' 100' ' ' GLN . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.524 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.9 -32.0 0.36 Allowed 'Trans proline' 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.42 147.9 43.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 129.951 3.301 . . . . 0.0 107.595 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 110.695 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.019 0.438 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 p -74.89 -55.44 5.8 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 127.726 2.41 . . . . 0.0 113.766 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.26 -8.89 37.84 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.801 1.24 . . . . 0.0 113.199 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.372 0.8 OUTLIER -69.13 -3.45 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 41.33 1.4 Allowed Glycine 0 C--N 1.365 2.173 0 O-C-N 119.978 -1.701 . . . . 0.0 109.776 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' CG ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG12 ' CG1' ' A' ' 14' ' ' VAL . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 56' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.489 HD22 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 64' ' ' ASP 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 62' ' ' PRO . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' HB2' ' HZ1' ' A' ' 97' ' ' LYS . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t -137.84 167.74 21.12 Favored 'General case' 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -39.17 153.75 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.315 1 N-CA-C 121.808 4.003 . . . . 0.0 121.808 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.87 -50.3 10.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 121.728 3.973 . . . . 0.0 121.728 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.2 6.77 20.89 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 126.874 2.069 . . . . 0.0 111.456 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -109.96 -26.4 9.77 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.763 1.225 . . . . 0.0 112.429 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.96 163.77 0.71 Allowed 'General case' 0 C--N 1.366 1.324 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.684 ' CD2' ' HH ' ' A' ' 93' ' ' TYR . 8.6 p80 -152.1 166.54 31.32 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.24 161.54 36.03 Favored 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.126 0.489 . . . . 0.0 110.438 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.347 19.7 ptpt -137.89 145.62 42.36 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 120.423 -1.423 . . . . 0.0 107.631 159.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 27.7 tt0 -128.25 161.37 29.51 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -59.71 77.48 0.01 OUTLIER 'General case' 0 C--N 1.359 1.009 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.91 3.92 23.03 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 126.811 2.148 . . . . 0.0 113.152 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 41.3 mm-40 -132.29 140.76 48.72 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 119.188 1.494 . . . . 0.0 107.89 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -133.46 122.9 24.33 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 -145.12 132.89 21.08 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 124.443 3.292 . . . . 0.0 112.475 171.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.684 ' HH ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HZ1' ' HB2' ' A' ' 69' ' ' ALA . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 24' ' ' PHE . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.47 -26.1 1.44 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.69 131.08 57.04 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 129.483 3.113 . . . . 0.0 106.982 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.354 0.764 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.323 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 p -101.76 -55.9 2.4 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.981 2.112 . . . . 0.0 114.408 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' HB3' HD13 ' A' ' 12' ' ' LEU . 98.2 m-85 -94.68 30.5 2.02 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 126.891 2.076 . . . . 0.0 115.25 -174.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.1 t -52.0 -30.97 13.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 130.098 3.359 . . . . 0.0 118.15 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA2' ' HZ3' ' A' ' 86' ' ' LYS . . . -126.64 40.83 1.72 Allowed Glycine 0 C--N 1.354 1.571 0 C-N-CA 126.354 1.931 . . . . 0.0 112.848 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG1' HG12 ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 14' ' ' VAL . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' HH ' ' CD1' ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' CD1' ' HH ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.483 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.428 ' CD1' ' HA2' ' A' ' 116' ' ' GLY 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 64' ' ' ASP . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m -139.58 168.87 18.84 Favored 'General case' 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.5 pm0 -38.53 159.23 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 121.094 3.738 . . . . 0.0 121.094 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -44.8 -50.24 10.29 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 120.956 3.687 . . . . 0.0 120.956 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -110.67 3.75 19.52 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.328 1.051 . . . . 0.0 110.084 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -116.37 -14.96 10.99 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -164.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.38 155.2 4.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.521 HG22 ' HH ' ' A' ' 93' ' ' TYR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.536 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 -152.12 166.51 31.44 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.16 163.99 38.93 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HZ3' ' HA2' ' A' ' 11' ' ' GLY . 14.3 tmtt? -137.46 138.58 39.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.64 160.59 22.2 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 m -58.87 66.07 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.06 4.14 18.88 Favored Glycine 0 C--N 1.356 1.662 0 C-N-CA 127.097 2.284 . . . . 0.0 113.709 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -127.4 138.6 53.03 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.77 136.45 54.43 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.96 121.54 24.12 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 115.698 -2.401 . . . . 0.0 105.891 165.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' HH ' HG22 ' A' ' 81' ' ' VAL . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.536 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.455 ' CG ' ' HB1' ' A' ' 108' ' ' ALA . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' HB2' ' A' ' 123' ' ' TYR . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.423 ' HB2' ' HG ' ' A' ' 119' ' ' LEU . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.47 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -96.07 20.66 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -104.02 119.26 38.56 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 121.284 1.856 . . . . 0.0 112.729 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.36 1.04 0 C-N-CA 126.311 1.844 . . . . 0.0 112.015 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 121.645 0.736 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -133.37 -105.36 0.24 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.065 1.346 . . . . 0.0 111.157 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . 0.329 50.3 p90 -125.27 35.83 4.69 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 125.912 1.685 . . . . 0.0 111.205 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.307 1.0 OUTLIER -77.0 6.24 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 170.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.73 25.81 4.65 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 129.418 3.389 . . . . 0.0 110.051 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' CG2' ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.412 ' N ' HG21 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD11 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 62' ' ' PRO 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.433 ' HD2' HG22 ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.418 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m -139.48 168.15 20.47 Favored 'General case' 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.3 pm0 -39.49 165.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.794 3.628 . . . . 0.0 120.794 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -44.97 -49.49 11.15 Favored 'General case' 0 N--CA 1.479 1.012 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.06 11.48 23.88 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 125.927 1.691 . . . . 0.0 111.754 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -115.86 -34.5 4.76 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.534 1.534 . . . . 0.0 111.644 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER -53.12 131.17 36.3 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 63' ' ' LEU 0.341 2.3 p80 -147.76 151.97 36.94 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 169.49 17.51 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.292 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -136.9 148.09 46.83 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 161.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -128.19 161.08 30.14 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -54.88 69.44 0.0 OUTLIER 'General case' 0 C--N 1.354 0.786 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.46 12.08 13.98 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 127.516 2.484 . . . . 0.0 112.066 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -132.69 150.56 52.14 Favored 'General case' 0 C--N 1.366 1.293 0 C-N-CA 125.932 1.693 . . . . 0.0 107.886 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.91 129.21 36.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 174.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 -146.08 138.2 25.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 114.157 -3.017 . . . . 0.0 113.01 167.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.511 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -81.95 -5.32 12.18 Favored 'Trans proline' 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.29 126.98 53.62 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.774 2.43 . . . . 0.0 105.061 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 C--N 1.352 0.712 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -177.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.9 p30 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-O 122.615 1.198 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 m -175.69 -174.79 0.71 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' H ' ' HB2' ' A' ' 32' ' ' ASP 0.302 8.1 m-30 -92.05 61.4 4.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 122.443 2.383 . . . . 0.0 112.618 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.309 1.6 m -84.54 5.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 130.053 3.341 . . . . 0.0 114.258 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.91 38.59 0.53 Allowed Glycine 0 C--N 1.369 2.378 0 O-C-N 118.209 -2.807 . . . . 0.0 109.733 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.685 HD21 ' H ' ' A' ' 13' ' ' ARG 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.685 ' H ' HD21 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG12 ' HZ3' ' A' ' 17' ' ' LYS . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.569 ' HE3' ' CE2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CD2' HD12 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 9' ' ' PHE . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 16' ' ' ALA 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 m -137.34 169.05 18.44 Favored 'General case' 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.27 168.27 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 130.859 3.664 . . . . 0.0 120.765 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -49.41 -50.22 41.5 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 121.571 3.915 . . . . 0.0 121.571 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -110.59 11.16 22.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 126.133 1.773 . . . . 0.0 112.074 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -110.97 -34.33 6.25 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.319 1.448 . . . . 0.0 111.481 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.12 144.88 18.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 59' ' ' ASP 0.304 0.8 OUTLIER -150.2 153.58 36.5 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.42 156.86 45.23 Favored 'General case' 0 C--N 1.372 1.574 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -173.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -137.85 141.68 40.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 90' ' ' GLU . 5.2 tm-20 -128.1 160.87 30.66 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -63.44 79.87 0.03 OUTLIER 'General case' 0 C--N 1.365 1.279 0 O-C-N 119.455 -2.028 . . . . 0.0 115.074 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.77 3.11 23.73 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 126.688 2.089 . . . . 0.0 113.832 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 29.1 mm-40 -131.47 137.35 48.55 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.26 124.71 27.84 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 -146.07 132.3 19.47 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.061 -3.056 . . . . 0.0 112.05 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 119' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -82.64 -8.95 11.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -117.74 148.95 41.54 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 127.956 2.503 . . . . 0.0 109.015 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.361 1.105 0 C-N-CA 125.958 1.703 . . . . 0.0 112.936 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 p -82.12 -21.24 36.78 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 128.633 2.773 . . . . 0.0 113.924 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.83 -27.16 14.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.588 1.555 . . . . 0.0 113.285 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.5 t -51.12 -17.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 130.508 3.523 . . . . 0.0 119.65 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.15 36.51 1.8 Allowed Glycine 0 C--N 1.346 1.089 0 C-N-CA 125.334 1.445 . . . . 0.0 111.777 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.511 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 29' ' ' ILE 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' ASP . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -137.95 167.51 21.61 Favored 'General case' 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.2 pm0 -39.53 171.66 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 121.65 3.944 . . . . 0.0 121.65 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.9 -49.44 29.88 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 121.782 3.993 . . . . 0.0 121.782 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -109.9 12.02 23.98 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 125.852 1.661 . . . . 0.0 111.015 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 90.2 m-85 -118.22 -31.14 5.09 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 125.838 1.655 . . . . 0.0 111.747 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER -53.61 127.03 23.89 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 173.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 -146.72 153.58 40.42 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 153.8 51.08 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 125.18 1.392 . . . . 0.0 107.857 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -136.81 124.52 22.44 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 162.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -123.23 160.43 26.61 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 126.117 1.767 . . . . 0.0 107.129 -175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.1 m -62.84 65.21 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.068 2.547 . . . . 0.0 116.867 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.02 13.8 8.24 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 127.453 2.454 . . . . 0.0 113.178 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.53 135.61 35.23 Favored 'General case' 0 C--N 1.368 1.396 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.0 126.59 44.56 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 119.951 -1.718 . . . . 0.0 106.952 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 -144.37 114.89 7.63 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 116.343 -2.143 . . . . 0.0 114.542 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.498 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.403 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 7.1 m120 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.402 HD11 ' HD2' ' A' ' 62' ' ' PRO . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' LEU . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 125' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -83.75 -27.09 1.78 Allowed 'Trans proline' 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -117.51 113.77 22.49 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 131.058 3.743 . . . . 0.0 103.839 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.353 0.75 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -175.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 p -104.25 20.67 17.94 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 125.604 1.562 . . . . 0.0 111.157 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -106.69 19.73 20.06 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 127.017 2.127 . . . . 0.0 112.678 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.28 -45.62 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.244 2.618 . . . . 0.0 114.851 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.19 52.37 0.64 Allowed Glycine 0 C--N 1.375 2.698 0 O-C-N 118.575 -2.578 . . . . 0.0 111.108 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' HA ' ' HZ2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 HG22 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 51' ' ' LEU 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.453 ' N ' HG21 ' A' ' 33' ' ' VAL . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' HG ' ' CZ ' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' HD22 ' A' ' 111' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t -139.06 168.58 19.53 Favored 'General case' 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -39.66 165.12 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -44.94 -49.47 11.08 Favored 'General case' 0 N--CA 1.48 1.063 1 N-CA-C 122.64 4.311 . . . . 0.0 122.64 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -111.04 10.93 22.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 126.211 1.804 . . . . 0.0 111.861 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.08 -32.16 5.81 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.488 1.515 . . . . 0.0 111.719 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER -53.21 138.15 32.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -142.18 147.84 37.25 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HD2' ' CD1' ' A' ' 92' ' ' TYR . 7.6 ptp180 -126.26 165.69 18.49 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 126.079 1.752 . . . . 0.0 108.677 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HZ2' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.42 146.94 42.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 108.635 160.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -128.23 160.83 30.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 p -72.39 72.8 0.98 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 119.166 -2.209 . . . . 0.0 114.918 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.28 7.91 13.7 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.653 2.073 . . . . 0.0 113.629 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.57 149.18 47.94 Favored 'General case' 0 C--N 1.367 1.363 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.37 135.49 44.74 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 -175.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' CD1' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -144.87 139.09 27.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 113.762 -3.175 . . . . 0.0 107.818 169.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 99' ' ' GLY . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 97' ' ' LYS . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HB3' ' CE2' ' A' ' 104' ' ' TYR . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.477 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.564 HE22 ' HA ' ' A' ' 67' ' ' VAL . 24.8 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HA ' HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.31 -5.49 15.04 Favored 'Trans proline' 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -117.17 131.33 56.9 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 124.762 1.225 . . . . 0.0 107.867 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.353 0.755 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.588 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.935 HD22 ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' H ' HD22 ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HG23 ' A' ' 29' ' ' ILE 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 14' ' ' VAL 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.774 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.791 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' VAL 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 55' ' ' ILE . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.791 HG21 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.521 HG23 ' HD2' ' A' ' 62' ' ' PRO 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD2' HG23 ' A' ' 61' ' ' ILE . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 67' ' ' VAL 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.43 HG23 ' HB ' ' A' ' 110' ' ' ILE 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' THR . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.877 0.846 . . . . 0.0 112.936 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB3' HD11 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 109' ' ' VAL . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 95' ' ' ILE 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 55' ' ' ILE . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.765 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' A' ' 41' ' ' LEU . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.02 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.498 ' SG ' HD22 ' A' ' 125' ' ' LEU 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' N ' ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' N ' ' A' ' 59' ' ' ASP 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 111' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.62 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 . . . . . 0 CA--C 1.504 -0.792 0 CA-C-O 121.681 0.753 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 95' ' ' ILE . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 93' ' ' TYR . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD12 HD11 ' A' ' 61' ' ' ILE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.62 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 119' ' ' LEU . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.868 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.8 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 111' ' ' LEU . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CG2' HG11 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.703 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.74 ' CG1' HD23 ' A' ' 111' ' ' LEU 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' CD ' HD12 ' A' ' 119' ' ' LEU . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 81' ' ' VAL 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 63' ' ' LEU . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 111.78 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 95' ' ' ILE . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 93' ' ' TYR . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 104' ' ' TYR 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.751 HD13 HD22 ' A' ' 56' ' ' LEU 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.425 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 125' ' ' LEU . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.625 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG23 ' A' ' 33' ' ' VAL . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.484 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.696 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.804 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.882 HD12 HD13 ' A' ' 119' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.565 HG21 ' CG2' ' A' ' 61' ' ' ILE 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.736 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 . . . . . 0 CA--C 1.499 -0.988 0 CA-C-O 123.6 1.667 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.419 ' HB3' HD11 ' A' ' 95' ' ' ILE . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 93' ' ' TYR . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.736 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.882 HD13 HD12 ' A' ' 61' ' ' ILE . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.804 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD21 ' A' ' 111' ' ' LEU . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CG ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 12' ' ' LEU . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HB2' HD12 ' A' ' 41' ' ' LEU . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.598 HD11 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 15' ' ' VAL 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 111' ' ' LEU . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 61' ' ' ILE 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 81' ' ' VAL 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 110' ' ' ILE 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 63' ' ' LEU . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.6 p80 . . . . . 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 122.536 1.16 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 93' ' ' TYR 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 70' ' ' LEU . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.617 ' O ' HD12 ' A' ' 61' ' ' ILE . 38.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HG ' HD11 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.282 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD11 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.564 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 56' ' ' LEU . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' HG12 ' A' ' 50' ' ' VAL . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.751 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 12' ' ' LEU . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.712 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CE2' HD12 ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 47' ' ' GLU 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.934 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 119' ' ' LEU 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 61' ' ' ILE . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.582 ' HB ' HG12 ' A' ' 81' ' ' VAL . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 65' ' ' THR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 . . . . . 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.547 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 95' ' ' ILE . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 61' ' ' ILE . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 120' ' ' ARG 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo . . . . . 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.0 HD22 ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.637 ' N ' HD23 ' A' ' 12' ' ' LEU . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 HG21 ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.61 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' C ' ' HB ' ' A' ' 14' ' ' VAL . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.798 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' C ' HG22 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' HG21 ' A' ' 33' ' ' VAL . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 55' ' ' ILE . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.0 ' HB2' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HD13 ' A' ' 119' ' ' LEU 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HB ' HG21 ' A' ' 67' ' ' VAL . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . 0.341 1.0 OUTLIER . . . . . 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 . . . . . 0 CA--C 1.494 -1.186 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.563 HG13 HG11 ' A' ' 109' ' ' VAL . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 95' ' ' ILE 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' PHE 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 120' ' ' ARG 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 61' ' ' ILE . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.65 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.48 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.887 HD11 ' HA ' ' A' ' 57' ' ' LEU 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HD22 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.676 ' HG3' ' HA ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' HG22 ' A' ' 110' ' ' ILE . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 37' ' ' LYS 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.827 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 55' ' ' ILE . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 40' ' ' LEU 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.887 ' HA ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CG1' HD22 ' A' ' 111' ' ' LEU 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' HD12 ' A' ' 119' ' ' LEU . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.657 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.482 HG23 ' CD1' ' A' ' 110' ' ' ILE 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 8.9 m . . . . . 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 67' ' ' VAL . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . 0.304 0.2 OUTLIER . . . . . 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 . . . . . 0 CA--C 1.501 -0.941 0 CA-C-O 121.647 0.737 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 95' ' ' ILE . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.531 HG13 HG21 ' A' ' 109' ' ' VAL . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.463 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.531 HG21 HG13 ' A' ' 95' ' ' ILE 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.79 HD11 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.657 HE22 ' HA ' ' A' ' 67' ' ' VAL . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 57' ' ' LEU . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 125' ' ' LEU . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.709 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.802 HG21 HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.865 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' HB ' ' A' ' 55' ' ' ILE . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.515 ' HB ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.749 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.814 ' CB ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' CD ' HD12 ' A' ' 119' ' ' LEU . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 63' ' ' LEU 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 . . . . . 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.418 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.476 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.769 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 87.2 m-20 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.589 HD13 HD13 ' A' ' 61' ' ' ILE . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.749 HD13 HD22 ' A' ' 56' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 60' ' ' PRO . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.676 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 12' ' ' LEU . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.765 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.42 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.765 HG21 HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.596 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' PRO 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HB3' HG11 ' A' ' 15' ' ' VAL . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 HD13 ' A' ' 119' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.597 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 93' ' ' TYR . 2.0 p80 . . . . . 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 84' ' ' HIS 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.444 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 95' ' ' ILE . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.675 ' H ' ' NE2' ' A' ' 115' ' ' GLN . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 24' ' ' PHE 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' H ' ' A' ' 112' ' ' SER . 36.1 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 61' ' ' ILE . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 m -162.77 -116.37 0.01 OUTLIER 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.892 -1.13 . . . . 0.0 113.628 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 12' ' ' LEU 0.253 42.0 p90 -114.28 40.82 2.42 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.234 1.413 . . . . 0.0 110.913 -175.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 32' ' ' ASP 0.302 2.8 m -76.26 5.97 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 174.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.34 31.08 2.46 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 128.408 2.908 . . . . 0.0 110.08 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.935 HD22 ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' H ' HD22 ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HG23 ' A' ' 29' ' ' ILE 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 14' ' ' VAL 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' HB2' HG12 ' A' ' 10' ' ' VAL . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.774 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.791 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' VAL 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 55' ' ' ILE . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.791 HG21 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.521 HG23 ' HD2' ' A' ' 62' ' ' PRO 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD2' HG23 ' A' ' 61' ' ' ILE . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 67' ' ' VAL 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.43 HG23 ' HB ' ' A' ' 110' ' ' ILE 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -137.37 168.05 20.4 Favored 'General case' 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.7 pm0 -38.4 159.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 1 N-CA-C 122.489 4.255 . . . . 0.0 122.489 -173.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.67 -50.48 63.17 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -167.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -110.48 -4.95 15.27 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.326 1.051 . . . . 0.0 109.698 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -118.88 6.12 11.43 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -161.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER -54.97 153.25 6.53 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 128.659 2.784 . . . . 0.0 118.132 174.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' THR . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -145.53 158.85 43.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.52 162.01 41.79 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.741 -173.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -138.05 129.06 27.19 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 166.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 31.6 tt0 -106.46 160.44 15.4 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.491 2.316 . . . . 0.0 106.789 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -65.76 66.11 0.04 OUTLIER 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.747 2.019 . . . . 0.0 116.228 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.95 14.16 8.06 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 127.59 2.519 . . . . 0.0 113.295 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 33.4 tt0 -140.68 139.79 34.84 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.06 132.05 41.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.772 -1.83 . . . . 0.0 108.777 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 -143.93 128.22 17.79 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 116.279 -2.169 . . . . 0.0 112.936 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB3' HD11 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 109' ' ' VAL . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 95' ' ' ILE 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.11 -24.51 3.86 Favored 'Trans proline' 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -118.39 158.28 25.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.779 3.232 . . . . 0.0 109.087 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 C--N 1.358 0.961 0 C-N-CA 126.078 1.751 . . . . 0.0 112.262 178.942 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.8 m -81.33 71.23 8.31 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.322 1.849 . . . . 0.0 113.858 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' HD13 ' A' ' 12' ' ' LEU 0.583 0.9 OUTLIER 78.05 -8.82 1.61 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 129.387 3.075 . . . . 0.0 117.113 179.416 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 10' ' ' VAL 0.286 1.6 m -67.26 5.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 118.884 2.92 . . . . 0.0 118.884 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.39 25.08 7.09 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 129.158 3.266 . . . . 0.0 111.796 170.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 55' ' ' ILE . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.765 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' A' ' 41' ' ' LEU . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.02 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.498 ' SG ' HD22 ' A' ' 125' ' ' LEU 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' N ' ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' N ' ' A' ' 59' ' ' ASP 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 111' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.62 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -137.76 169.18 18.24 Favored 'General case' 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -38.09 144.05 0.11 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -43.42 -50.03 6.98 Favored 'General case' 0 C--N 1.361 1.083 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.37 0.8 16.75 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 121.319 1.872 . . . . 0.0 110.59 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -119.81 9.78 11.43 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 120.527 -1.358 . . . . 0.0 113.727 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -55.09 162.72 1.25 Allowed 'General case' 0 C--N 1.352 0.679 1 C-N-CA 132.796 4.438 . . . . 0.0 116.322 172.426 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.64 152.43 40.46 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 146.2 47.2 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -138.2 128.51 26.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 167.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -123.34 161.18 25.18 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.811 2.044 . . . . 0.0 106.307 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 p -61.3 76.15 0.01 OUTLIER 'General case' 0 C--N 1.359 1.011 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.29 2.72 31.3 Favored Glycine 0 C--N 1.359 1.81 0 C-N-CA 127.367 2.413 . . . . 0.0 113.779 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -128.55 111.86 13.7 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.82 119.4 35.88 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 117.145 -1.407 . . . . 0.0 107.745 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 -144.68 127.31 16.12 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 113.985 -3.086 . . . . 0.0 111.154 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 95' ' ' ILE . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 93' ' ' TYR . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD12 HD11 ' A' ' 61' ' ' ILE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.62 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 119' ' ' LEU . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.868 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.76 -11.11 12.77 Favored 'Trans proline' 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -113.84 118.96 35.69 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.678 2.391 . . . . 0.0 104.806 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.356 0.852 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.827 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.8 t30 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -67.95 41.62 0.03 OUTLIER 'General case' 0 C--N 1.358 0.957 1 C-N-CA 131.873 4.069 . . . . 0.0 117.598 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HD22 ' A' ' 12' ' ' LEU . 2.2 t80 -113.21 -61.94 1.66 Allowed 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 127.331 2.252 . . . . 0.0 105.195 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 10' ' ' VAL 0.41 27.2 m -60.45 6.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 176.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.83 22.57 16.26 Favored Glycine 0 C--N 1.351 1.416 1 C-N-CA 132.741 4.972 . . . . 0.0 110.878 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 111' ' ' LEU . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CG2' HG11 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.703 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.74 ' CG1' HD23 ' A' ' 111' ' ' LEU 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' CD ' HD12 ' A' ' 119' ' ' LEU . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 81' ' ' VAL 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m -139.02 167.45 22.02 Favored 'General case' 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.79 169.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.22 -46.19 34.93 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 120.796 3.628 . . . . 0.0 120.796 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.86 9.46 24.59 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.147 1.779 . . . . 0.0 110.613 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.88 -33.24 3.8 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 120.413 -1.429 . . . . 0.0 112.813 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.61 141.02 27.08 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 63' ' ' LEU . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -140.74 149.86 42.68 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -130.13 162.13 29.53 Favored 'General case' 0 C--N 1.37 1.459 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.63 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -137.81 139.96 40.27 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 158.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 29.9 tt0 -116.41 161.19 19.45 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.016 2.127 . . . . 0.0 106.34 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 65.01 0.01 OUTLIER 'General case' 0 C--N 1.365 1.254 0 C-N-CA 127.114 2.166 . . . . 0.0 115.729 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.89 8.04 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 127.697 2.57 . . . . 0.0 112.992 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 34.8 tt0 -140.49 142.92 35.25 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.57 131.96 40.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 O-C-N 119.754 -1.842 . . . . 0.0 108.151 -172.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.36 138.44 27.81 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 115.037 -2.665 . . . . 0.0 111.78 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 95' ' ' ILE . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 93' ' ' TYR . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 104' ' ' TYR 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.751 HD13 HD22 ' A' ' 56' ' ' LEU 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -95.65 33.45 0.16 Allowed 'Trans proline' 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -116.09 132.68 56.59 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 120.625 1.557 . . . . 0.0 112.428 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--N 1.352 0.703 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.237 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -135.57 8.96 3.37 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.079 1.752 . . . . 0.0 109.601 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 6.9 p90 -121.79 32.67 5.77 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.869 1.668 . . . . 0.0 111.008 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.401 1.5 m -72.97 6.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.71 26.73 3.14 Favored Glycine 0 C--N 1.358 1.8 0 C-N-CA 128.606 3.003 . . . . 0.0 111.237 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 125' ' ' LEU . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.625 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG23 ' A' ' 33' ' ' VAL . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.484 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.696 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.804 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.882 HD12 HD13 ' A' ' 119' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.565 HG21 ' CG2' ' A' ' 61' ' ' ILE 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.736 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m -137.48 168.84 18.85 Favored 'General case' 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.6 pm0 -37.73 156.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -48.67 -51.14 29.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 120.557 3.54 . . . . 0.0 120.557 -164.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -110.75 -8.68 14.54 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.909 1.284 . . . . 0.0 109.544 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.16 4.68 21.29 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -163.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.13 158.67 2.83 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 129.201 3.0 . . . . 0.0 118.496 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 149.28 45.84 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 161.87 36.88 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.14 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.27 24.9 pttm -137.68 148.4 45.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.919 161.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -117.96 161.41 19.83 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 128.41 2.684 . . . . 0.0 106.026 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -59.03 64.83 0.0 OUTLIER 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.495 2.318 . . . . 0.0 116.908 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.13 13.85 8.14 Favored Glycine 0 C--N 1.356 1.651 0 C-N-CA 127.397 2.427 . . . . 0.0 112.741 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -139.9 147.84 41.17 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.38 129.63 37.67 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 -145.72 136.23 24.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 123.456 2.844 . . . . 0.0 112.228 169.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.419 ' HB3' HD11 ' A' ' 95' ' ' ILE . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 93' ' ' TYR . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.736 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.882 HD13 HD12 ' A' ' 61' ' ' ILE . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.804 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.9 -32.0 0.36 Allowed 'Trans proline' 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.42 147.9 43.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 129.951 3.301 . . . . 0.0 107.595 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 110.695 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.019 0.438 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 p -74.89 -55.44 5.8 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 127.726 2.41 . . . . 0.0 113.766 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 12' ' ' LEU . 23.8 m-85 -94.26 -8.89 37.84 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.801 1.24 . . . . 0.0 113.199 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 10' ' ' VAL 0.372 0.8 OUTLIER -69.13 -3.45 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.368 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 41.33 1.4 Allowed Glycine 0 C--N 1.365 2.173 0 O-C-N 119.978 -1.701 . . . . 0.0 109.776 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD21 ' A' ' 111' ' ' LEU . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CG ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 12' ' ' LEU . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HB2' HD12 ' A' ' 41' ' ' LEU . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.598 HD11 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 15' ' ' VAL 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 111' ' ' LEU . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 61' ' ' ILE 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 81' ' ' VAL 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 110' ' ' ILE 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t -137.84 167.74 21.12 Favored 'General case' 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.7 pm0 -39.17 153.75 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.315 1 N-CA-C 121.808 4.003 . . . . 0.0 121.808 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.87 -50.3 10.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 121.728 3.973 . . . . 0.0 121.728 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.2 6.77 20.89 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 126.874 2.069 . . . . 0.0 111.456 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -109.96 -26.4 9.77 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.763 1.225 . . . . 0.0 112.429 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.96 163.77 0.71 Allowed 'General case' 0 C--N 1.366 1.324 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 63' ' ' LEU . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.6 p80 -152.1 166.54 31.32 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.24 161.54 36.03 Favored 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.126 0.489 . . . . 0.0 110.438 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.347 19.7 ptpt -137.89 145.62 42.36 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 120.423 -1.423 . . . . 0.0 107.631 159.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -128.25 161.37 29.51 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -59.71 77.48 0.01 OUTLIER 'General case' 0 C--N 1.359 1.009 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.91 3.92 23.03 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 126.811 2.148 . . . . 0.0 113.152 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -132.29 140.76 48.72 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 119.188 1.494 . . . . 0.0 107.89 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -133.46 122.9 24.33 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 -145.12 132.89 21.08 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 124.443 3.292 . . . . 0.0 112.475 171.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 93' ' ' TYR 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 70' ' ' LEU . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.617 ' O ' HD12 ' A' ' 61' ' ' ILE . 38.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HG ' HD11 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.47 -26.1 1.44 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.69 131.08 57.04 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 129.483 3.113 . . . . 0.0 106.982 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.354 0.764 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.323 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 p -101.76 -55.9 2.4 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.981 2.112 . . . . 0.0 114.408 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HB3' HD12 ' A' ' 12' ' ' LEU . 98.2 m-85 -94.68 30.5 2.02 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 126.891 2.076 . . . . 0.0 115.25 -174.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 10' ' ' VAL . 10.1 t -52.0 -30.97 13.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 130.098 3.359 . . . . 0.0 118.15 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.64 40.83 1.72 Allowed Glycine 0 C--N 1.354 1.571 0 C-N-CA 126.354 1.931 . . . . 0.0 112.848 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD11 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 56' ' ' LEU . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' HG12 ' A' ' 50' ' ' VAL . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.751 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 12' ' ' LEU . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.712 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CE2' HD12 ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 47' ' ' GLU 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.934 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 119' ' ' LEU 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 61' ' ' ILE . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.582 ' HB ' HG12 ' A' ' 81' ' ' VAL . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m -139.58 168.87 18.84 Favored 'General case' 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.5 pm0 -38.53 159.23 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 121.094 3.738 . . . . 0.0 121.094 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -44.8 -50.24 10.29 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 120.956 3.687 . . . . 0.0 120.956 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -110.67 3.75 19.52 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.328 1.051 . . . . 0.0 110.084 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -116.37 -14.96 10.99 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -164.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.38 155.2 4.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 65' ' ' THR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 -152.12 166.51 31.44 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.16 163.99 38.93 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -137.46 138.58 39.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.64 160.59 22.2 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 m -58.87 66.07 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.06 4.14 18.88 Favored Glycine 0 C--N 1.356 1.662 0 C-N-CA 127.097 2.284 . . . . 0.0 113.709 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -127.4 138.6 53.03 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.77 136.45 54.43 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.96 121.54 24.12 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 115.698 -2.401 . . . . 0.0 105.891 165.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.547 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 95' ' ' ILE . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 61' ' ' ILE . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 120' ' ' ARG 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -96.07 20.66 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -104.02 119.26 38.56 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 121.284 1.856 . . . . 0.0 112.729 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.36 1.04 0 C-N-CA 126.311 1.844 . . . . 0.0 112.015 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 121.645 0.736 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -133.37 -105.36 0.24 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.065 1.346 . . . . 0.0 111.157 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD2' HD13 ' A' ' 12' ' ' LEU 0.329 50.3 p90 -125.27 35.83 4.69 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 125.912 1.685 . . . . 0.0 111.205 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.307 1.0 OUTLIER -77.0 6.24 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 170.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.73 25.81 4.65 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 129.418 3.389 . . . . 0.0 110.051 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.0 HD22 ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.637 ' N ' HD23 ' A' ' 12' ' ' LEU . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 HG21 ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.61 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' C ' ' HB ' ' A' ' 14' ' ' VAL . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.798 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' C ' HG22 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' HG21 ' A' ' 33' ' ' VAL . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 55' ' ' ILE . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.0 ' HB2' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HD13 ' A' ' 119' ' ' LEU 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m -139.48 168.15 20.47 Favored 'General case' 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.3 pm0 -39.49 165.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.794 3.628 . . . . 0.0 120.794 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -44.97 -49.49 11.15 Favored 'General case' 0 N--CA 1.479 1.012 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.06 11.48 23.88 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 125.927 1.691 . . . . 0.0 111.754 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -115.86 -34.5 4.76 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.534 1.534 . . . . 0.0 111.644 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER -53.12 131.17 36.3 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HB ' HG21 ' A' ' 67' ' ' VAL . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . 0.341 1.0 OUTLIER -147.76 151.97 36.94 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 169.49 17.51 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.292 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -136.9 148.09 46.83 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 161.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -128.19 161.08 30.14 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -54.88 69.44 0.0 OUTLIER 'General case' 0 C--N 1.354 0.786 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.46 12.08 13.98 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 127.516 2.484 . . . . 0.0 112.066 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -132.69 150.56 52.14 Favored 'General case' 0 C--N 1.366 1.293 0 C-N-CA 125.932 1.693 . . . . 0.0 107.886 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -133.91 129.21 36.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 174.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 -146.08 138.2 25.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 114.157 -3.017 . . . . 0.0 113.01 167.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.563 HG13 HG11 ' A' ' 109' ' ' VAL . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 95' ' ' ILE 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' PHE 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 120' ' ' ARG 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 61' ' ' ILE . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.65 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -81.95 -5.32 12.18 Favored 'Trans proline' 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.29 126.98 53.62 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.774 2.43 . . . . 0.0 105.061 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 C--N 1.352 0.712 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -177.141 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.9 p30 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-O 122.615 1.198 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 m -175.69 -174.79 0.71 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.49 ' H ' ' HB2' ' A' ' 32' ' ' ASP 0.302 8.1 m-30 -92.05 61.4 4.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 122.443 2.383 . . . . 0.0 112.618 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.309 1.6 m -84.54 5.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 130.053 3.341 . . . . 0.0 114.258 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.91 38.59 0.53 Allowed Glycine 0 C--N 1.369 2.378 0 O-C-N 118.209 -2.807 . . . . 0.0 109.733 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.887 HD11 ' HA ' ' A' ' 57' ' ' LEU 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HD22 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.676 ' HG3' ' HA ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' HG22 ' A' ' 110' ' ' ILE . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 9' ' ' PHE . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 37' ' ' LYS 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.827 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 55' ' ' ILE . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 40' ' ' LEU 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.887 ' HA ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CG1' HD22 ' A' ' 111' ' ' LEU 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' HD12 ' A' ' 119' ' ' LEU . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.657 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.482 HG23 ' CD1' ' A' ' 110' ' ' ILE 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 8.9 m -137.34 169.05 18.44 Favored 'General case' 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.27 168.27 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 130.859 3.664 . . . . 0.0 120.765 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -49.41 -50.22 41.5 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 121.571 3.915 . . . . 0.0 121.571 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -110.59 11.16 22.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 126.133 1.773 . . . . 0.0 112.074 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -110.97 -34.33 6.25 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.319 1.448 . . . . 0.0 111.481 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -54.12 144.88 18.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 175.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 67' ' ' VAL . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . 0.304 0.2 OUTLIER -150.2 153.58 36.5 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.42 156.86 45.23 Favored 'General case' 0 C--N 1.372 1.574 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -173.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -137.85 141.68 40.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.1 160.87 30.66 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -63.44 79.87 0.03 OUTLIER 'General case' 0 C--N 1.365 1.279 0 O-C-N 119.455 -2.028 . . . . 0.0 115.074 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.77 3.11 23.73 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 126.688 2.089 . . . . 0.0 113.832 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -131.47 137.35 48.55 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.26 124.71 27.84 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 -146.07 132.3 19.47 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.061 -3.056 . . . . 0.0 112.05 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 95' ' ' ILE . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.531 HG13 HG21 ' A' ' 109' ' ' VAL . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.463 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.531 HG21 HG13 ' A' ' 95' ' ' ILE 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.79 HD11 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.657 HE22 ' HA ' ' A' ' 67' ' ' VAL . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -82.64 -8.95 11.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -117.74 148.95 41.54 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 127.956 2.503 . . . . 0.0 109.015 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.361 1.105 0 C-N-CA 125.958 1.703 . . . . 0.0 112.936 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 p -82.12 -21.24 36.78 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 128.633 2.773 . . . . 0.0 113.924 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.83 -27.16 14.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.588 1.555 . . . . 0.0 113.285 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 10' ' ' VAL . 71.5 t -51.12 -17.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 130.508 3.523 . . . . 0.0 119.65 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.15 36.51 1.8 Allowed Glycine 0 C--N 1.346 1.089 0 C-N-CA 125.334 1.445 . . . . 0.0 111.777 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 57' ' ' LEU . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 125' ' ' LEU . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.709 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.802 HG21 HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.865 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' HB ' ' A' ' 55' ' ' ILE . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.515 ' HB ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.749 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.814 ' CB ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' CD ' HD12 ' A' ' 119' ' ' LEU . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 63' ' ' LEU 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -137.95 167.51 21.61 Favored 'General case' 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.2 pm0 -39.53 171.66 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 121.65 3.944 . . . . 0.0 121.65 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.9 -49.44 29.88 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 121.782 3.993 . . . . 0.0 121.782 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -109.9 12.02 23.98 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 125.852 1.661 . . . . 0.0 111.015 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -118.22 -31.14 5.09 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 125.838 1.655 . . . . 0.0 111.747 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER -53.61 127.03 23.89 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 173.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 -146.72 153.58 40.42 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 153.8 51.08 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 125.18 1.392 . . . . 0.0 107.857 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -136.81 124.52 22.44 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 162.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -123.23 160.43 26.61 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 126.117 1.767 . . . . 0.0 107.129 -175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.1 m -62.84 65.21 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.068 2.547 . . . . 0.0 116.867 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.02 13.8 8.24 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 127.453 2.454 . . . . 0.0 113.178 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.53 135.61 35.23 Favored 'General case' 0 C--N 1.368 1.396 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.0 126.59 44.56 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 119.951 -1.718 . . . . 0.0 106.952 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.418 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 -144.37 114.89 7.63 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 116.343 -2.143 . . . . 0.0 114.542 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.476 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.769 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 87.2 m-20 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.589 HD13 HD13 ' A' ' 61' ' ' ILE . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.749 HD13 HD22 ' A' ' 56' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -83.75 -27.09 1.78 Allowed 'Trans proline' 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -117.51 113.77 22.49 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 131.058 3.743 . . . . 0.0 103.839 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.353 0.75 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -175.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 p -104.25 20.67 17.94 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 125.604 1.562 . . . . 0.0 111.157 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 57' ' ' LEU . 54.9 m-85 -106.69 19.73 20.06 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 127.017 2.127 . . . . 0.0 112.678 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.28 -45.62 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.244 2.618 . . . . 0.0 114.851 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.19 52.37 0.64 Allowed Glycine 0 C--N 1.375 2.698 0 O-C-N 118.575 -2.578 . . . . 0.0 111.108 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 60' ' ' PRO . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.676 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 12' ' ' LEU . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.765 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.42 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.765 HG21 HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.596 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' PRO 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HB3' HG11 ' A' ' 15' ' ' VAL . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 HD13 ' A' ' 119' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.597 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t -139.06 168.58 19.53 Favored 'General case' 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.3 pm0 -39.66 165.12 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -44.94 -49.47 11.08 Favored 'General case' 0 N--CA 1.48 1.063 1 N-CA-C 122.64 4.311 . . . . 0.0 122.64 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -111.04 10.93 22.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 126.211 1.804 . . . . 0.0 111.861 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.08 -32.16 5.81 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.488 1.515 . . . . 0.0 111.719 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER -53.21 138.15 32.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 93' ' ' TYR . 2.0 p80 -142.18 147.84 37.25 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HD2' ' CD1' ' A' ' 92' ' ' TYR . 7.6 ptp180 -126.26 165.69 18.49 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 126.079 1.752 . . . . 0.0 108.677 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.42 146.94 42.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 108.635 160.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -128.23 160.83 30.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 p -72.39 72.8 0.98 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 119.166 -2.209 . . . . 0.0 114.918 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.28 7.91 13.7 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.653 2.073 . . . . 0.0 113.629 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.57 149.18 47.94 Favored 'General case' 0 C--N 1.367 1.363 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' HG ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -133.37 135.49 44.74 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 -175.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -144.87 139.09 27.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 113.762 -3.175 . . . . 0.0 107.818 169.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 84' ' ' HIS 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.444 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 95' ' ' ILE . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.675 ' H ' ' NE2' ' A' ' 115' ' ' GLN . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 24' ' ' PHE 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' H ' ' A' ' 112' ' ' SER . 36.1 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 61' ' ' ILE . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.31 -5.49 15.04 Favored 'Trans proline' 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -117.17 131.33 56.9 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 124.762 1.225 . . . . 0.0 107.867 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.353 0.755 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.588 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.935 HD22 ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' H ' HD22 ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HG23 ' A' ' 29' ' ' ILE 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 14' ' ' VAL 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.774 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.791 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' VAL 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 55' ' ' ILE . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.791 HG21 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.521 HG23 ' HD2' ' A' ' 62' ' ' PRO 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD2' HG23 ' A' ' 61' ' ' ILE . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 67' ' ' VAL 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.43 HG23 ' HB ' ' A' ' 110' ' ' ILE 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' THR . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.877 0.846 . . . . 0.0 112.936 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB3' HD11 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 109' ' ' VAL . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 95' ' ' ILE 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.556 HE22 ' HA ' ' A' ' 67' ' ' VAL . 42.3 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 55' ' ' ILE . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.765 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' A' ' 41' ' ' LEU . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.02 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.498 ' SG ' HD22 ' A' ' 125' ' ' LEU 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' N ' ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' N ' ' A' ' 59' ' ' ASP 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 111' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.62 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 1.2 p80 . . . . . 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 . . . . . 0 CA--C 1.504 -0.792 0 CA-C-O 121.681 0.753 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 93' ' ' TYR . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD12 HD11 ' A' ' 61' ' ' ILE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.62 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 119' ' ' LEU . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.868 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.8 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 111' ' ' LEU . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CG2' HG11 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.703 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.74 ' CG1' HD23 ' A' ' 111' ' ' LEU 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' CD ' HD12 ' A' ' 119' ' ' LEU . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 81' ' ' VAL 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 63' ' ' LEU . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.564 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 121.192 0.52 . . . . 0.0 111.78 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 93' ' ' TYR . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.596 ' HD2' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 104' ' ' TYR 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.751 HD13 HD22 ' A' ' 56' ' ' LEU 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.425 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 125' ' ' LEU . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.625 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG23 ' A' ' 33' ' ' VAL . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.484 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.696 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.804 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.882 HD12 HD13 ' A' ' 119' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.565 HG21 ' CG2' ' A' ' 61' ' ' ILE 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.736 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.521 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 . . . . . 0 CA--C 1.499 -0.988 0 CA-C-O 123.6 1.667 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 93' ' ' TYR . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.54 HE22 ' CD ' ' A' ' 102' ' ' LYS . 1.1 pp0? -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.54 ' CD ' HE22 ' A' ' 100' ' ' GLN . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.736 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.882 HD13 HD12 ' A' ' 61' ' ' ILE . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.804 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD21 ' A' ' 111' ' ' LEU . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CG ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 12' ' ' LEU . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HB2' HD12 ' A' ' 41' ' ' LEU . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.598 HD11 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 15' ' ' VAL 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 111' ' ' LEU . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 61' ' ' ILE 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 81' ' ' VAL 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 110' ' ' ILE 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 63' ' ' LEU . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.6 p80 . . . . . 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 122.536 1.16 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 93' ' ' TYR 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 70' ' ' LEU . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.617 ' O ' HD12 ' A' ' 61' ' ' ILE . 33.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HG ' HD11 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.282 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD11 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.564 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 56' ' ' LEU . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' HG12 ' A' ' 50' ' ' VAL . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.751 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 12' ' ' LEU . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.712 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CE2' HD12 ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 47' ' ' GLU 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.934 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 119' ' ' LEU 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 61' ' ' ILE . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.582 ' HB ' HG12 ' A' ' 81' ' ' VAL . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 65' ' ' THR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 . . . . . 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.547 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 95' ' ' ILE . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 61' ' ' ILE . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 120' ' ' ARG 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo . . . . . 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.0 HD22 ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.637 ' N ' HD23 ' A' ' 12' ' ' LEU . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 HG21 ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.61 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' C ' ' HB ' ' A' ' 14' ' ' VAL . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.798 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' C ' HG22 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' HG21 ' A' ' 33' ' ' VAL . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 55' ' ' ILE . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.0 ' HB2' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HD13 ' A' ' 119' ' ' LEU 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HB ' HG21 ' A' ' 67' ' ' VAL . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.425 ' CE1' HD21 ' A' ' 63' ' ' LEU 0.341 2.3 p80 . . . . . 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 . . . . . 0 CA--C 1.494 -1.186 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.563 HG13 HG11 ' A' ' 109' ' ' VAL . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 95' ' ' ILE 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' PHE 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 120' ' ' ARG 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 61' ' ' ILE . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.65 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.48 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.887 HD11 ' HA ' ' A' ' 57' ' ' LEU 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HD22 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.676 ' HG3' ' HA ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' HG22 ' A' ' 110' ' ' ILE . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 37' ' ' LYS 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.827 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 55' ' ' ILE . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 40' ' ' LEU 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.887 ' HA ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CG1' HD22 ' A' ' 111' ' ' LEU 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' HD12 ' A' ' 119' ' ' LEU . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.657 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.482 HG23 ' CD1' ' A' ' 110' ' ' ILE 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 8.9 m . . . . . 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 67' ' ' VAL . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 59' ' ' ASP 0.304 0.8 OUTLIER . . . . . 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 . . . . . 0 CA--C 1.501 -0.941 0 CA-C-O 121.647 0.737 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 95' ' ' ILE . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.531 HG13 HG21 ' A' ' 109' ' ' VAL . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.463 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.531 HG21 HG13 ' A' ' 95' ' ' ILE 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.79 HD11 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.657 HE22 ' HA ' ' A' ' 67' ' ' VAL . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 57' ' ' LEU . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 125' ' ' LEU . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.709 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.802 HG21 HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.865 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' HB ' ' A' ' 55' ' ' ILE . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.515 ' HB ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.749 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.814 ' CB ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' CD ' HD12 ' A' ' 119' ' ' LEU . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 63' ' ' LEU 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 . . . . . 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.418 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.476 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.769 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 7.1 m120 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.589 HD13 HD13 ' A' ' 61' ' ' ILE . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.749 HD13 HD22 ' A' ' 56' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 60' ' ' PRO . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.676 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 12' ' ' LEU . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.765 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.42 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.765 HG21 HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.596 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' PRO 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HB3' HG11 ' A' ' 15' ' ' VAL . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 HD13 ' A' ' 119' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.597 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.881 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 93' ' ' TYR . 2.0 p80 . . . . . 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 84' ' ' HIS 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.444 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 95' ' ' ILE . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 24' ' ' PHE 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.881 HE22 ' HA ' ' A' ' 67' ' ' VAL . 24.8 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 61' ' ' ILE . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 m -162.77 -116.37 0.01 OUTLIER 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.892 -1.13 . . . . 0.0 113.628 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 12' ' ' LEU 0.253 42.0 p90 -114.28 40.82 2.42 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 125.234 1.413 . . . . 0.0 110.913 -175.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 32' ' ' ASP 0.302 2.8 m -76.26 5.97 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 174.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.34 31.08 2.46 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 128.408 2.908 . . . . 0.0 110.08 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.935 HD22 ' H ' ' A' ' 13' ' ' ARG 0.41 0.1 OUTLIER -59.97 167.04 2.42 Favored 'General case' 0 CA--C 1.556 1.188 1 C-N-CA 133.537 4.735 . . . . 0.0 116.265 179.244 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' H ' HD22 ' A' ' 12' ' ' LEU . 97.6 mtt180 -106.5 117.54 34.32 Favored 'General case' 0 C--N 1.362 1.114 1 C-N-CA 131.781 4.033 . . . . 0.0 106.57 -174.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG11 HG23 ' A' ' 29' ' ' ILE 0.37 14.8 m -123.2 167.9 16.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 O-C-N 118.106 -2.871 . . . . 0.0 117.127 -169.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -117.65 148.2 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 C-N-CA 128.212 2.605 . . . . 0.0 105.825 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.81 107.89 10.26 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.331 1.852 . . . . 0.0 113.448 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -131.21 125.19 32.28 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 103.792 -2.669 . . . . 0.0 103.792 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -90.62 -53.51 4.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 118.545 -2.597 . . . . 0.0 111.502 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 p -112.48 147.38 36.64 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 m -82.45 107.79 15.37 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 119.665 -1.897 . . . . 0.0 108.098 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.41 9.24 6.06 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 127.727 2.411 . . . . 0.0 111.085 -170.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.45 -18.8 54.77 Favored Glycine 0 CA--C 1.493 -1.313 0 CA-C-O 114.886 -3.175 . . . . 0.0 117.997 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.384 1.0 OUTLIER -136.27 149.96 48.71 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 123.454 3.627 . . . . 0.0 117.098 174.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.267 0.0 OUTLIER -118.24 148.6 42.25 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.411 2.684 . . . . 0.0 111.171 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -96.56 -174.88 3.15 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.724 4.41 . . . . 0.0 107.82 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 t -109.61 149.6 29.44 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 118.754 -2.466 . . . . 0.0 115.437 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.95 166.81 25.58 Favored Glycine 0 C--N 1.358 1.776 1 C-N-CA 131.13 4.205 . . . . 0.0 113.04 178.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -135.27 134.25 39.76 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.71 -2.053 . . . . 0.0 112.257 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 14' ' ' VAL 0.501 1.4 pt -83.77 155.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.399 2.733 0 CA-C-N 124.696 3.407 . . . . 0.0 117.547 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.8 m -110.91 -35.59 5.91 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 127.926 2.491 . . . . 0.0 111.239 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -157.58 165.76 34.7 Favored 'General case' 0 C--N 1.374 1.668 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' HB2' HG12 ' A' ' 10' ' ' VAL . 31.2 t70 -96.49 132.68 41.82 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 120.228 -1.545 . . . . 0.0 109.882 171.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -107.21 126.31 63.35 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.01 -145.3 0.07 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 121.965 3.546 . . . . 0.0 121.965 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.03 112.8 26.06 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.596 1.558 . . . . 0.0 108.458 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.64 -14.53 57.68 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 125.983 1.754 . . . . 0.0 113.258 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.774 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.344 0.7 OUTLIER -105.67 164.58 11.8 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 120.147 1.973 . . . . 0.0 113.563 -174.145 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -141.06 137.75 33.12 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 128.346 2.658 . . . . 0.0 108.029 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -109.97 108.22 18.39 Favored 'General case' 0 C--N 1.391 2.381 0 N-CA-C 101.284 -3.598 . . . . 0.0 101.284 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.791 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.97 159.03 42.78 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-N 110.825 -2.898 . . . . 0.0 117.68 -161.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 10.1 tt -129.69 142.9 50.63 Favored 'General case' 0 CA--C 1.477 -1.827 0 O-C-N 120.193 -1.567 . . . . 0.0 107.143 173.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 2.8 m-85 -66.74 153.39 43.4 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 123.216 2.735 . . . . 0.0 111.797 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.51 -10.82 1.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 118.804 -2.435 . . . . 0.0 116.609 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -115.29 2.17 13.94 Favored 'General case' 0 N--CA 1.427 -1.615 1 C-N-CA 132.455 4.302 . . . . 0.0 113.2 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 97.97 39.31 3.85 Favored Glycine 0 C--N 1.381 3.053 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 168.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -122.09 102.26 8.04 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 120.137 1.968 . . . . 0.0 107.152 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.261 33.5 tt0 -98.49 151.27 20.79 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -175.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.4 178.0 7.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.779 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' VAL 0.251 1.2 m-20 -125.45 136.91 53.88 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 99.832 -4.136 . . . . 0.0 99.832 164.517 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 55' ' ' ILE . 7.4 m -147.89 166.96 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 123.046 0.538 . . . . 0.0 110.138 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -84.68 140.5 31.26 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-O 122.488 1.137 . . . . 0.0 108.125 169.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -74.48 -29.3 62.02 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -149.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 0.29 0.23 Allowed 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 127.764 2.426 . . . . 0.0 115.226 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -109.4 -75.23 0.63 Allowed 'General case' 0 N--CA 1.432 -1.365 1 C-N-CA 135.407 5.483 . . . . 0.0 106.615 173.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.791 HG21 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -115.84 101.92 12.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 O-C-N 118.33 -2.731 . . . . 0.0 111.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.304 4.0 pp -134.98 161.66 34.66 Favored 'General case' 0 C--N 1.369 1.438 0 N-CA-C 121.457 3.873 . . . . 0.0 121.457 -169.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HA ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.91 102.1 0.04 OUTLIER 'General case' 0 C--N 1.374 1.648 1 C-N-CA 132.191 4.196 . . . . 0.0 118.566 172.512 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.1 OUTLIER -124.88 175.54 7.22 Favored 'General case' 0 N--CA 1.395 -3.195 0 C-N-CA 127.841 2.456 . . . . 0.0 107.07 -175.068 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -84.87 -43.03 0.69 Allowed Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 128.898 2.879 . . . . 0.0 107.259 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.274 10.6 Cg_endo -55.87 -78.86 0.0 OUTLIER 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 125.658 3.056 . . . . 0.0 117.318 2.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.521 HG23 ' HD2' ' A' ' 62' ' ' PRO 0.31 0.3 OUTLIER -124.55 161.02 50.58 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 120.391 1.451 . . . . 0.0 114.571 -159.528 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD2' HG23 ' A' ' 61' ' ' ILE . 71.3 Cg_exo -52.88 127.01 23.1 Favored 'Trans proline' 0 C--N 1.375 1.926 1 C-N-CA 127.919 5.746 . . . . 0.0 118.622 -167.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.496 2.3 mp -46.25 14.98 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 2 C-N-CA 136.758 6.023 . . . . 0.0 123.7 -179.774 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.408 14.8 m-20 -143.93 27.87 1.44 Allowed 'General case' 0 N--CA 1.434 -1.242 1 C-N-CA 133.975 4.91 . . . . 0.0 108.516 -172.726 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 67' ' ' VAL 0.287 47.9 m -113.14 106.18 14.35 Favored 'General case' 0 CA--C 1.443 -3.146 0 O-C-N 120.007 -1.683 . . . . 0.0 113.347 -162.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -66.71 93.99 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.732 159.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -108.72 172.96 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.419 1 C-N-CA 135.96 5.704 . . . . 0.0 105.21 -175.506 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.43 HG23 ' HB ' ' A' ' 110' ' ' ILE 0.27 5.0 t -98.95 144.78 27.73 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.0 141.28 47.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.438 2.295 . . . . 0.0 109.964 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.264 0.1 OUTLIER -65.35 97.16 0.26 Allowed 'General case' 0 C--N 1.368 1.392 0 CA-C-O 126.938 3.256 . . . . 0.0 117.039 -173.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -137.37 168.05 20.4 Favored 'General case' 0 N--CA 1.433 -1.318 3 C-N-CA 137.606 6.362 . . . . 0.0 98.655 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.7 pm0 -38.4 159.47 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 1 N-CA-C 122.489 4.255 . . . . 0.0 122.489 -173.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.67 -50.48 63.17 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -167.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -110.48 -4.95 15.27 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.326 1.051 . . . . 0.0 109.698 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -118.88 6.12 11.43 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -161.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.284 0.1 OUTLIER -54.97 153.25 6.53 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 128.659 2.784 . . . . 0.0 118.132 174.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.5 m -116.49 153.15 32.65 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.075 -1.016 . . . . 0.0 113.158 -169.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.28 . . -94.25 151.52 19.38 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 119.646 3.202 . . . . 0.0 119.646 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.65 165.78 34.66 Favored Glycine 0 C--N 1.364 2.129 0 N-CA-C 105.131 -3.187 . . . . 0.0 105.131 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' THR . 97.3 t -105.18 120.88 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 117.544 2.424 . . . . 0.0 117.544 -164.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.99 128.44 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 121.359 1.89 . . . . 0.0 112.354 164.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.79 -48.17 0.81 Allowed 'General case' 0 C--N 1.37 1.478 0 C-N-CA 125.414 1.486 . . . . 0.0 111.681 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -136.19 130.64 5.37 Favored Glycine 0 C--N 1.366 2.197 0 O-C-N 120.273 -1.517 . . . . 0.0 110.823 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -145.53 158.85 43.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.518 -1.578 . . . . 0.0 113.601 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.52 162.01 41.79 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.741 -173.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -138.05 129.06 27.19 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 166.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 31.6 tt0 -106.46 160.44 15.4 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.491 2.316 . . . . 0.0 106.789 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -65.76 66.11 0.04 OUTLIER 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.747 2.019 . . . . 0.0 116.228 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.95 14.16 8.06 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 127.59 2.519 . . . . 0.0 113.295 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 33.4 tt0 -140.68 139.79 34.84 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.06 132.05 41.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.772 -1.83 . . . . 0.0 108.777 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.438 2.3 p90 -143.93 128.22 17.79 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 116.279 -2.169 . . . . 0.0 112.936 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB3' HD11 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -109.41 119.07 38.34 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.121 2.569 . . . . 0.0 106.583 177.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 103' ' ' TRP 0.335 77.7 p -92.24 109.68 21.05 Favored 'General case' 0 C--N 1.376 1.753 0 CA-C-O 124.322 2.01 . . . . 0.0 109.002 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.659 HD12 HG11 ' A' ' 109' ' ' VAL . 7.2 mm -99.9 115.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 110.877 -2.874 . . . . 0.0 103.757 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -87.54 110.27 20.23 Favored 'General case' 0 C--N 1.364 1.227 0 O-C-N 120.397 -1.439 . . . . 0.0 109.339 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.261 43.5 tptt -143.52 130.94 21.0 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.597 -161.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 66.99 3.49 3.14 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.957 2.103 . . . . 0.0 114.366 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.29 22.97 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.194 2.331 . . . . 0.0 111.162 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -130.88 170.15 14.81 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.728 1.211 . . . . 0.0 112.563 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -98.99 124.87 44.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 119.699 -1.876 . . . . 0.0 111.602 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -104.59 117.59 34.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 79.4 m95 -99.04 107.54 19.98 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 26.2 m-85 -125.54 143.49 50.99 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 124.583 1.153 . . . . 0.0 109.107 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -67.47 129.32 39.53 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 120.093 -1.629 . . . . 0.0 107.946 162.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -31.45 -24.8 0.0 OUTLIER 'General case' 0 C--N 1.35 0.6 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -160.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.2 ptm -65.14 -16.42 63.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.241 2.616 . . . . 0.0 115.371 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -90.83 8.86 32.7 Favored 'General case' 0 C--N 1.389 2.316 0 O-C-N 120.252 -1.53 . . . . 0.0 113.911 174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 95' ' ' ILE 0.346 16.2 m -124.43 149.51 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 C-N-CA 128.803 2.841 . . . . 0.0 105.413 165.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -133.27 166.49 29.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 109.432 -3.531 . . . . 0.0 104.757 177.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -145.47 155.22 42.97 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.853 -1.154 . . . . 0.0 108.417 171.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.6 p -100.5 164.61 11.82 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.06 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.304 3.0 mt -54.1 -52.31 61.43 Favored 'General case' 0 C--N 1.386 2.186 0 CA-C-N 121.725 2.057 . . . . 0.0 114.526 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.602 3.2 mt-10 -66.27 -18.37 65.31 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 118.954 2.946 . . . . 0.0 118.954 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.556 HE22 ' HA ' ' A' ' 67' ' ' VAL . 42.3 mt-30 -82.32 -12.36 58.03 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.922 1.689 . . . . 0.0 111.868 166.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.2 -41.7 3.93 Favored Glycine 0 C--N 1.35 1.331 1 C-N-CA 132.574 4.892 . . . . 0.0 111.956 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -73.01 -26.46 61.33 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 130.033 3.333 . . . . 0.0 115.272 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 2.7 ptp180 -64.2 -34.42 78.05 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 123.397 1.57 . . . . 0.0 111.576 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 125' ' ' LEU . 5.5 tt -88.04 -45.68 9.98 Favored 'General case' 0 C--N 1.37 1.486 1 C-N-CA 137.039 6.135 . . . . 0.0 111.658 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -39.69 -31.61 0.11 Allowed 'General case' 0 C--N 1.362 1.122 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -168.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 9.4 pt-20 -88.85 -31.22 18.39 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 130.309 3.443 . . . . 0.0 113.778 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -99.73 -42.17 6.97 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.015 2.526 . . . . 0.0 114.292 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -130.02 6.22 5.0 Favored 'General case' 0 C--N 1.375 1.696 0 CA-C-O 114.961 -2.447 . . . . 0.0 117.384 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.17 -72.33 0.16 Allowed Glycine 0 CA--C 1.46 -3.363 2 C-N-CA 113.205 -4.331 . . . . 0.0 108.625 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.726 1.2 mm? -48.54 14.19 0.0 OUTLIER 'General case' 0 C--N 1.385 2.136 0 N-CA-C 121.251 3.796 . . . . 0.0 121.251 -163.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 97.89 0.11 Allowed Glycine 0 C--N 1.362 2.024 0 CA-C-O 115.719 -2.712 . . . . 0.0 116.099 158.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -82.11 -24.51 3.86 Favored 'Trans proline' 0 C--N 1.366 1.491 1 CA-C-N 128.07 5.935 . . . . 0.0 112.242 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -118.39 158.28 25.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.779 3.232 . . . . 0.0 109.087 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 C--N 1.358 0.961 0 C-N-CA 126.078 1.751 . . . . 0.0 112.262 178.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.8 m -81.33 71.23 8.31 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.322 1.849 . . . . 0.0 113.858 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.508 ' CD1' HD13 ' A' ' 12' ' ' LEU 0.583 0.9 OUTLIER 78.05 -8.82 1.61 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 129.387 3.075 . . . . 0.0 117.113 179.416 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 10' ' ' VAL 0.286 1.6 m -67.26 5.62 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 118.884 2.92 . . . . 0.0 118.884 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.39 25.08 7.09 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 129.158 3.266 . . . . 0.0 111.796 170.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.587 0.0 OUTLIER -68.58 168.34 13.19 Favored 'General case' 0 C--N 1.372 1.582 0 C-N-CA 129.777 3.231 . . . . 0.0 117.795 176.665 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.06 121.34 33.52 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 128.677 2.791 . . . . 0.0 106.919 -167.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 55' ' ' ILE . 16.2 t -126.19 155.84 36.31 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 CA-C-O 123.021 1.391 . . . . 0.0 113.181 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -116.08 136.94 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 C-N-CA 130.275 3.43 . . . . 0.0 104.717 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -122.48 106.7 11.26 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.388 1.68 . . . . 0.0 109.704 -168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.13 121.23 17.83 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.568 1.947 . . . . 0.0 109.063 -175.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.273 82.7 m95 -92.23 -81.65 0.34 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 118.979 -2.325 . . . . 0.0 114.726 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -107.64 151.44 25.64 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.903 -1.748 . . . . 0.0 108.233 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 m -65.1 108.88 1.98 Allowed 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -123.52 -10.2 7.92 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 128.361 2.664 . . . . 0.0 112.324 -168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 95.73 -19.66 53.33 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 127.379 2.419 . . . . 0.0 114.129 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.494 4.5 p90 -137.72 164.08 29.73 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 119.362 3.097 . . . . 0.0 119.362 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -115.48 141.1 48.51 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 127.454 2.302 . . . . 0.0 105.383 174.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.18 -175.24 3.62 Favored 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 133.695 4.798 . . . . 0.0 104.643 175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.1 p -105.24 140.76 37.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.73 2.412 . . . . 0.0 117.504 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.0 165.95 25.53 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 128.66 3.029 . . . . 0.0 111.952 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -128.1 166.6 18.15 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.966 2.883 . . . . 0.0 104.357 165.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.95 153.91 6.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 O-C-N 119.736 -1.852 . . . . 0.0 109.837 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.3 m -114.0 -44.97 3.1 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.824 1.649 . . . . 0.0 110.221 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -150.89 161.2 43.16 Favored 'General case' 0 C--N 1.368 1.372 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -89.68 141.98 28.11 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 118.306 -2.746 . . . . 0.0 110.27 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.03 122.08 64.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 176.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 27.56 -124.67 0.06 OUTLIER Glycine 0 C--N 1.359 1.829 1 C-N-CA 131.315 4.293 . . . . 0.0 121.682 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 123.24 47.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.868 2.067 . . . . 0.0 108.175 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.36 83.23 Favored Glycine 0 C--N 1.356 1.66 0 C-N-CA 124.983 1.278 . . . . 0.0 115.666 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.765 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.266 0.1 OUTLIER -128.8 166.33 19.24 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 119.739 1.77 . . . . 0.0 112.752 -175.728 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.67 144.84 35.89 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 128.628 2.771 . . . . 0.0 108.483 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -114.37 107.97 16.27 Favored 'General case' 0 C--N 1.381 1.967 1 N-CA-C 99.106 -4.405 . . . . 0.0 99.106 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.51 147.81 51.63 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-N 111.681 -2.509 . . . . 0.0 114.591 -158.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.338 7.6 tt -130.62 127.07 38.22 Favored 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 119.336 -2.102 . . . . 0.0 107.619 175.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -65.54 154.06 39.7 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.726 -1.858 . . . . 0.0 113.375 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -61.67 -2.51 0.82 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.661 2.096 . . . . 0.0 116.661 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.22 -4.35 13.08 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 130.378 3.471 . . . . 0.0 111.565 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.32 23.36 12.81 Favored Glycine 0 C--N 1.38 3.01 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -102.01 112.8 25.57 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 119.996 1.898 . . . . 0.0 108.037 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' A' ' 41' ' ' LEU . 2.3 tm-20 -103.49 152.57 21.51 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.833 1.301 . . . . 0.0 113.492 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.84 179.39 5.94 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.7 138.98 54.43 Favored 'General case' 0 C--N 1.352 0.703 1 N-CA-C 99.8 -4.148 . . . . 0.0 99.8 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 m -148.0 166.71 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 CA-C-N 119.348 0.976 . . . . 0.0 111.76 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 3.6 mm? -79.89 140.48 36.72 Favored 'General case' 0 C--N 1.374 1.662 0 C-N-CA 126.146 1.778 . . . . 0.0 108.674 168.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -67.63 -37.62 89.46 Favored Glycine 0 C--N 1.367 2.259 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -147.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 27.15 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 130.879 3.672 . . . . 0.0 115.293 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 52' ' ' GLY . 63.4 m-20 -136.84 -73.13 0.43 Allowed 'General case' 0 N--CA 1.423 -1.791 1 C-N-CA 132.021 4.128 . . . . 0.0 104.247 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -129.11 99.85 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 O-C-N 119.119 -2.238 . . . . 0.0 109.722 -178.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -135.4 162.72 31.81 Favored 'General case' 0 C--N 1.374 1.669 1 N-CA-C 123.093 4.479 . . . . 0.0 123.093 -169.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.02 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.302 0.3 OUTLIER -48.78 107.48 0.14 Allowed 'General case' 0 C--N 1.4 2.769 0 CA-C-O 127.936 3.731 . . . . 0.0 118.032 163.248 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.498 ' SG ' HD22 ' A' ' 125' ' ' LEU 0.284 0.3 OUTLIER -124.04 174.93 7.3 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 -179.639 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' N ' ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -81.56 -41.79 1.07 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 127.721 2.408 . . . . 0.0 108.476 163.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' N ' ' A' ' 59' ' ' ASP 0.346 26.5 Cg_exo -65.53 -75.6 0.0 OUTLIER 'Cis proline' 0 CA--C 1.472 -2.58 0 CA-C-N 124.514 2.648 . . . . 0.0 116.603 2.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 111' ' ' LEU 0.392 7.4 mm -100.77 157.17 34.21 Favored Pre-proline 0 N--CA 1.438 -1.043 0 O-C-N 124.05 0.844 . . . . 0.0 112.558 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.62 ' HD3' HD12 ' A' ' 119' ' ' LEU . 77.9 Cg_exo -63.94 117.79 4.77 Favored 'Trans proline' 0 C--N 1.366 1.49 1 C-N-CA 125.862 4.375 . . . . 0.0 112.168 -167.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.456 1.1 mt -37.85 14.84 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.337 2 N-CA-C 126.687 5.81 . . . . 0.0 126.687 -166.927 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -162.32 48.25 0.17 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 126.696 1.998 . . . . 0.0 106.705 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 95.1 m -116.78 132.13 56.77 Favored 'General case' 0 CA--C 1.454 -2.714 0 C-N-CA 127.284 2.234 . . . . 0.0 111.668 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 31.2 mt-10 -64.5 94.34 0.12 Allowed 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 113.827 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.81 171.1 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.645 0 C-N-CA 126.317 1.847 . . . . 0.0 106.977 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.259 5.6 t -100.08 138.31 37.33 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.8 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.55 141.6 35.1 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.66 1.584 . . . . 0.0 111.248 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.464 3.9 mm? -67.45 102.06 1.07 Allowed 'General case' 0 C--N 1.373 1.614 0 CA-C-O 126.66 3.124 . . . . 0.0 115.372 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -137.76 169.18 18.24 Favored 'General case' 0 N--CA 1.422 -1.826 3 C-N-CA 137.676 6.39 . . . . 0.0 96.715 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -38.09 144.05 0.11 Allowed 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -43.42 -50.03 6.98 Favored 'General case' 0 C--N 1.361 1.083 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -164.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.37 0.8 16.75 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 121.319 1.872 . . . . 0.0 110.59 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -119.81 9.78 11.43 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 120.527 -1.358 . . . . 0.0 113.727 -164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -55.09 162.72 1.25 Allowed 'General case' 0 C--N 1.352 0.679 1 C-N-CA 132.796 4.438 . . . . 0.0 116.322 172.426 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.0 p -126.55 154.46 43.84 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 119.225 -2.172 . . . . 0.0 113.987 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.328 . . -83.68 139.06 33.01 Favored 'General case' 0 C--N 1.37 1.468 0 CA-C-O 123.949 1.833 . . . . 0.0 114.527 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -139.02 -167.65 11.01 Favored Glycine 0 CA--C 1.466 -2.978 1 N-CA-C 101.166 -4.773 . . . . 0.0 101.166 176.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.23 138.41 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.107 0 O-C-N 120.331 -1.688 . . . . 0.0 110.43 -172.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.19 130.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 161.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -125.37 -40.25 2.13 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 146.11 11.71 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 120.535 -1.353 . . . . 0.0 110.494 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 1.2 p80 -144.64 152.43 40.46 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 146.2 47.2 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -138.2 128.51 26.05 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 167.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -123.34 161.18 25.18 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 126.811 2.044 . . . . 0.0 106.307 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 p -61.3 76.15 0.01 OUTLIER 'General case' 0 C--N 1.359 1.011 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.29 2.72 31.3 Favored Glycine 0 C--N 1.359 1.81 0 C-N-CA 127.367 2.413 . . . . 0.0 113.779 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -128.55 111.86 13.7 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.82 119.4 35.88 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 117.145 -1.407 . . . . 0.0 107.745 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.389 2.4 p90 -144.68 127.31 16.12 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 113.985 -3.086 . . . . 0.0 111.154 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 5.4 m-85 -106.46 128.83 54.37 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.4 p -91.41 95.62 10.08 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 126.115 1.766 . . . . 0.0 106.566 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 93' ' ' TYR . 48.0 mm -99.08 120.06 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -87.43 114.06 23.7 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.296 -0.878 . . . . 0.0 108.997 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -143.1 126.41 16.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.586 -159.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 64.64 3.94 2.14 Favored 'General case' 0 C--N 1.363 1.191 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.35 -14.55 10.91 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.413 2.435 . . . . 0.0 110.939 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -119.29 170.71 8.87 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.144 1.778 . . . . 0.0 113.427 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -97.78 127.26 43.61 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 119.245 -2.16 . . . . 0.0 111.913 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -105.49 127.36 52.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -99.91 104.89 16.56 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 103.202 -2.888 . . . . 0.0 103.202 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.19 123.52 44.55 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.934 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -64.5 143.95 57.54 Favored 'General case' 0 C--N 1.377 1.774 0 C-N-CA 126.564 1.945 . . . . 0.0 109.725 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -30.83 -47.79 0.1 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.614 3.165 . . . . 0.0 119.017 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -61.04 -11.28 7.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.51 -5.84 45.14 Favored 'General case' 0 C--N 1.369 1.45 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.85 133.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 131.291 3.836 . . . . 0.0 107.366 172.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.3 pp -140.52 -172.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 O-C-N 120.587 -1.321 . . . . 0.0 111.1 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD12 HD11 ' A' ' 61' ' ' ILE . 1.3 pt? -148.43 151.43 35.22 Favored 'General case' 0 C--N 1.372 1.568 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -84.08 159.46 21.13 Favored 'General case' 0 C--N 1.363 1.186 1 C-N-CA 131.937 4.095 . . . . 0.0 111.704 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.579 0.0 OUTLIER -60.93 -27.67 68.39 Favored 'General case' 0 C--N 1.397 2.662 0 CA-C-N 123.546 2.885 . . . . 0.0 116.245 176.006 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.537 5.4 mt-10 -86.32 -11.04 53.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 123.101 2.682 . . . . 0.0 116.271 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.21 -31.25 20.41 Favored 'General case' 0 C--N 1.365 1.246 0 O-C-N 120.956 -1.09 . . . . 0.0 109.43 164.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.76 -46.23 7.98 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 119.796 2.679 . . . . 0.0 119.796 172.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 58.4 m-20 -76.61 -19.16 58.12 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.094 -2.415 . . . . 0.0 112.727 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -26.36 65.95 Favored 'General case' 0 C--N 1.361 1.105 0 O-C-N 120.946 -1.096 . . . . 0.0 110.594 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.62 HD12 ' HD3' ' A' ' 62' ' ' PRO . 4.2 tt -88.5 -38.13 15.22 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 131.227 3.811 . . . . 0.0 111.303 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 7.0 ptm180 -49.31 -30.85 8.05 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -94.13 -22.46 18.45 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 131.095 3.758 . . . . 0.0 112.723 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -104.99 -46.32 4.31 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 126.1 1.76 . . . . 0.0 114.965 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 119' ' ' LEU . 16.7 m-85 -131.06 9.54 4.87 Favored 'General case' 0 C--N 1.376 1.733 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -170.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.9 -72.01 0.17 Allowed Glycine 1 CA--C 1.448 -4.135 1 C-N-CA 113.401 -4.238 . . . . 0.0 106.168 -172.537 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.868 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.487 0.0 OUTLIER -49.33 13.08 0.0 OUTLIER 'General case' 0 C--N 1.356 0.849 1 N-CA-C 123.046 4.461 . . . . 0.0 123.046 -162.86 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.1 94.65 0.09 OUTLIER Glycine 0 C--N 1.353 1.513 0 CA-C-O 115.644 -2.753 . . . . 0.0 117.941 157.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.76 -11.11 12.77 Favored 'Trans proline' 0 C--N 1.364 1.351 1 CA-C-N 127.149 5.474 . . . . 0.0 113.184 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -113.84 118.96 35.69 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.678 2.391 . . . . 0.0 104.806 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.356 0.852 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.8 t30 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -67.95 41.62 0.03 OUTLIER 'General case' 0 C--N 1.358 0.957 1 C-N-CA 131.873 4.069 . . . . 0.0 117.598 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HD22 ' A' ' 12' ' ' LEU . 2.2 t80 -113.21 -61.94 1.66 Allowed 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 127.331 2.252 . . . . 0.0 105.195 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 10' ' ' VAL 0.41 27.2 m -60.45 6.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 176.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.83 22.57 16.26 Favored Glycine 0 C--N 1.351 1.416 1 C-N-CA 132.741 4.972 . . . . 0.0 110.878 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 166.23 0.02 OUTLIER 'General case' 0 C--N 1.371 1.521 1 C-N-CA 135.716 5.606 . . . . 0.0 117.763 175.881 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -113.59 114.9 27.11 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 103.276 -2.861 . . . . 0.0 103.276 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 29' ' ' ILE 0.436 4.4 m -121.22 161.53 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 119.635 -1.916 . . . . 0.0 114.895 -170.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 111' ' ' LEU . 1.5 m -116.21 146.55 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.591 0 C-N-CA 128.211 2.605 . . . . 0.0 107.012 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' TYR . . . -127.44 106.91 9.51 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 124.248 1.975 . . . . 0.0 113.53 -169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.44 112.04 8.76 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 128.087 2.555 . . . . 0.0 106.322 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -85.27 -29.79 24.31 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 124.45 3.295 . . . . 0.0 114.582 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.0 m -128.65 151.72 49.18 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 100.933 -3.729 . . . . 0.0 100.933 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -72.94 108.12 5.68 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 121.964 2.165 . . . . 0.0 109.99 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -28.97 11.97 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.194 2.197 . . . . 0.0 116.349 -165.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.36 27.98 Favored Glycine 0 C--O 1.217 -0.926 0 C-N-CA 128.814 3.102 . . . . 0.0 112.903 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.559 0.1 OUTLIER -136.86 149.1 47.49 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 121.401 2.601 . . . . 0.0 114.241 164.155 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -117.97 151.43 37.47 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.477 2.311 . . . . 0.0 109.548 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 13.0 m-85 -93.44 -173.92 3.35 Favored 'General case' 0 N--CA 1.444 -0.752 1 C-N-CA 135.863 5.665 . . . . 0.0 106.961 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.253 0.3 OUTLIER -133.72 138.12 45.63 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -170.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.12 168.59 25.04 Favored Glycine 0 C--N 1.366 2.243 1 C-N-CA 133.649 5.404 . . . . 0.0 115.971 -163.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -136.65 142.72 43.24 Favored 'General case' 0 C--N 1.369 1.42 0 O-C-N 119.662 -2.081 . . . . 0.0 111.694 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CG2' HG11 ' A' ' 14' ' ' VAL 0.551 0.2 OUTLIER -88.74 157.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.399 2.726 2 CA-C-N 126.063 4.029 . . . . 0.0 114.87 175.567 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -111.41 -40.65 4.32 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.47 1.908 . . . . 0.0 111.155 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.38 166.3 31.43 Favored 'General case' 0 C--N 1.37 1.482 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -94.08 134.35 36.59 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 120.63 -1.294 . . . . 0.0 109.416 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.703 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -111.09 124.06 67.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.22 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 36.93 -130.71 1.06 Allowed Glycine 0 C--N 1.357 1.718 0 N-CA-C 121.99 3.556 . . . . 0.0 121.99 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.87 119.74 39.96 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.138 2.175 . . . . 0.0 109.067 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.07 -19.43 30.65 Favored Glycine 0 C--N 1.35 1.315 0 C-N-CA 125.497 1.522 . . . . 0.0 115.035 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.703 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 2.1 pttp -97.38 159.7 14.76 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-O 123.989 1.852 . . . . 0.0 114.926 -175.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -138.18 146.55 42.83 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 126.566 1.946 . . . . 0.0 108.619 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -111.83 105.11 13.49 Favored 'General case' 0 C--N 1.378 1.838 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.44 161.05 36.56 Favored 'General case' 0 CA--C 1.477 -1.864 0 CA-C-N 111.074 -2.784 . . . . 0.0 116.284 -162.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.36 9.9 tt -129.91 146.81 51.62 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 119.804 -1.81 . . . . 0.0 107.44 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.89 141.97 38.74 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 118.242 -2.786 . . . . 0.0 106.984 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -49.95 -17.84 0.44 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 118.958 2.948 . . . . 0.0 118.958 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -97.05 -6.18 35.85 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 130.269 3.427 . . . . 0.0 113.986 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.9 11.58 Favored Glycine 0 C--N 1.373 2.591 0 N-CA-C 120.196 2.838 . . . . 0.0 120.196 166.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -92.73 107.3 19.11 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.869 2.335 . . . . 0.0 109.364 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.258 30.2 tt0 -101.99 153.84 19.51 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.35 177.55 7.46 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -172.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.284 1.5 m-20 -125.53 139.89 53.22 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 100.475 -3.898 . . . . 0.0 100.475 166.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.65 164.24 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.42 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -85.57 132.42 34.18 Favored 'General case' 0 C--N 1.374 1.638 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -66.55 -41.02 94.36 Favored Glycine 0 CA--C 1.459 -3.45 0 CA-C-N 113.858 -1.519 . . . . 0.0 116.561 -140.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 17.94 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 130.336 3.454 . . . . 0.0 117.131 -175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 52' ' ' GLY . 90.9 m-20 -126.72 -79.5 0.6 Allowed 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 136.602 5.961 . . . . 0.0 104.222 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -113.09 98.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 O-C-N 118.728 -2.483 . . . . 0.0 107.703 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.2 157.42 46.95 Favored 'General case' 0 C--N 1.371 1.54 1 N-CA-C 122.239 4.163 . . . . 0.0 122.239 -164.228 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -52.46 102.85 0.06 Allowed 'General case' 0 C--N 1.373 1.629 1 C-N-CA 132.004 4.122 . . . . 0.0 117.552 172.971 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.284 0.1 OUTLIER -124.94 175.05 7.57 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 128.141 2.576 . . . . 0.0 108.232 -175.775 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.55 -38.19 0.49 Allowed Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 130.544 3.538 . . . . 0.0 110.336 166.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.294 6.2 Cg_exo -64.53 -73.48 0.0 OUTLIER 'Cis proline' 0 C--N 1.38 2.203 0 CA-C-N 124.629 2.689 . . . . 0.0 114.851 0.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.74 ' CG1' HD23 ' A' ' 111' ' ' LEU 0.295 7.3 mm -104.74 159.46 29.26 Favored Pre-proline 0 N--CA 1.437 -1.085 0 O-C-N 124.29 0.994 . . . . 0.0 113.239 -163.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' CD ' HD12 ' A' ' 119' ' ' LEU . 11.0 Cg_exo -52.98 106.1 0.14 Allowed 'Trans proline' 0 C--N 1.365 1.401 1 C-N-CA 128.58 6.187 . . . . 0.0 115.014 -170.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 81' ' ' VAL 0.309 0.9 OUTLIER -38.1 13.48 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.436 2 N-CA-C 128.211 6.375 . . . . 0.0 128.211 -167.537 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -159.12 40.44 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.9 m -118.1 158.47 24.97 Favored 'General case' 0 CA--C 1.447 -2.997 0 C-N-CA 126.865 2.066 . . . . 0.0 111.534 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.76 120.82 11.43 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 131.681 3.992 . . . . 0.0 110.135 168.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.359 0.0 OUTLIER -158.16 174.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.484 -1.591 1 C-N-CA 133.495 4.718 . . . . 0.0 105.801 -176.541 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 t -134.12 158.06 44.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 124.461 2.077 . . . . 0.0 113.175 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.72 137.74 38.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 128.358 2.663 . . . . 0.0 109.845 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.77 117.18 25.36 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 123.478 1.609 . . . . 0.0 112.305 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m -139.02 167.45 22.02 Favored 'General case' 0 N--CA 1.439 -0.996 1 C-N-CA 133.078 4.551 . . . . 0.0 101.328 170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.79 169.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.22 -46.19 34.93 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 120.796 3.628 . . . . 0.0 120.796 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.86 9.46 24.59 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.147 1.779 . . . . 0.0 110.613 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.88 -33.24 3.8 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 120.413 -1.429 . . . . 0.0 112.813 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.61 141.02 27.08 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 161.74 37.1 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.428 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.91 158.32 16.83 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.3 -164.91 16.15 Favored Glycine 0 C--N 1.355 1.604 1 C-N-CA 130.742 4.02 . . . . 0.0 108.59 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 t -117.7 147.1 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 O-C-N 120.171 -1.782 . . . . 0.0 111.417 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 63' ' ' LEU . 8.9 p -90.87 131.74 37.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -119.86 -46.93 2.42 Favored 'General case' 0 C--N 1.361 1.106 0 O-C-N 124.832 1.332 . . . . 0.0 111.713 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.99 147.52 11.28 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.564 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -140.74 149.86 42.68 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -130.13 162.13 29.53 Favored 'General case' 0 C--N 1.37 1.459 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.63 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -137.81 139.96 40.27 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 158.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 29.9 tt0 -116.41 161.19 19.45 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.016 2.127 . . . . 0.0 106.34 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 65.01 0.01 OUTLIER 'General case' 0 C--N 1.365 1.254 0 C-N-CA 127.114 2.166 . . . . 0.0 115.729 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.89 8.04 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 127.697 2.57 . . . . 0.0 112.992 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 34.8 tt0 -140.49 142.92 35.25 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.57 131.96 40.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 O-C-N 119.754 -1.842 . . . . 0.0 108.151 -172.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.36 138.44 27.81 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 115.037 -2.665 . . . . 0.0 111.78 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -113.53 125.35 54.09 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.2 p -87.67 98.69 11.58 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 125.747 1.619 . . . . 0.0 108.233 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 93' ' ' TYR . 28.6 mm -101.2 118.05 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 107.269 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.25 107.21 18.39 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 123.328 1.537 . . . . 0.0 109.469 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.313 0.1 OUTLIER -143.95 133.1 22.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 112.664 -2.062 . . . . 0.0 111.667 -160.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 67.37 3.44 3.29 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.614 1.966 . . . . 0.0 114.321 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.91 -4.67 22.51 Favored Glycine 0 C--N 1.357 1.698 0 C-N-CA 127.641 2.543 . . . . 0.0 111.556 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -136.24 170.97 15.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.848 1.259 . . . . 0.0 112.83 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.75 122.66 35.37 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 118.93 -2.356 . . . . 0.0 112.532 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -95.72 154.86 17.0 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -126.43 104.66 8.28 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 28.5 m-85 -125.93 130.21 50.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.104 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.596 ' HD2' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -64.06 148.74 49.07 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 126.182 1.793 . . . . 0.0 110.337 165.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -30.98 -41.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 129.399 3.08 . . . . 0.0 119.067 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ptm -61.85 -18.96 61.99 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 127.637 2.375 . . . . 0.0 116.846 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 104' ' ' TYR 0.265 . . -102.7 9.39 39.21 Favored 'General case' 0 C--N 1.372 1.58 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 p -123.84 115.57 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.99 176.87 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.388 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.83 155.54 41.07 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 126.635 1.974 . . . . 0.0 113.855 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 84.5 p -100.5 175.55 5.64 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 110.501 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.461 0.7 OUTLIER -62.62 -53.49 53.8 Favored 'General case' 0 C--N 1.389 2.317 0 CA-C-N 122.826 2.557 . . . . 0.0 115.478 177.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.665 14.7 mt-10 -62.18 -9.66 8.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -78.5 -48.1 16.0 Favored 'General case' 0 C--N 1.361 1.085 1 C-N-CA 131.829 4.052 . . . . 0.0 110.5 165.637 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -79.28 -42.86 11.23 Favored Glycine 0 C--N 1.356 1.661 1 C-N-CA 132.082 4.658 . . . . 0.0 118.277 177.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -76.68 -25.57 53.82 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 131.045 3.738 . . . . 0.0 112.52 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -70.91 -22.22 62.28 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.228 1.489 . . . . 0.0 111.648 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 61' ' ' ILE . 5.8 tt -93.0 -39.21 11.24 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 130.511 3.525 . . . . 0.0 110.785 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -46.86 -34.91 5.8 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -94.08 -16.49 23.76 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 129.208 3.003 . . . . 0.0 114.275 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -104.73 -44.86 4.75 Favored 'General case' 0 C--N 1.366 1.326 0 C-N-CA 125.227 1.411 . . . . 0.0 112.751 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -131.77 6.54 4.35 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.51 -77.74 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.162 1 C-N-CA 113.313 -4.28 . . . . 0.0 106.587 -168.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.751 HD13 HD22 ' A' ' 56' ' ' LEU 0.507 2.4 mm? -49.16 9.27 0.0 OUTLIER 'General case' 0 C--N 1.378 1.828 0 N-CA-C 121.614 3.931 . . . . 0.0 121.614 -162.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.77 88.23 0.1 Allowed Glycine 0 C--N 1.359 1.823 0 N-CA-C 119.334 2.494 . . . . 0.0 119.334 168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -95.65 33.45 0.16 Allowed 'Trans proline' 0 CA--C 1.55 1.306 1 CA-C-N 125.612 4.706 . . . . 0.0 111.384 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -116.09 132.68 56.59 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 120.625 1.557 . . . . 0.0 112.428 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--N 1.352 0.703 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.237 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -135.57 8.96 3.37 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 126.079 1.752 . . . . 0.0 109.601 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 6.9 p90 -121.79 32.67 5.77 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.869 1.668 . . . . 0.0 111.008 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.401 1.5 m -72.97 6.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.71 26.73 3.14 Favored Glycine 0 C--N 1.358 1.8 0 C-N-CA 128.606 3.003 . . . . 0.0 111.237 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 57' ' ' LEU 0.603 0.0 OUTLIER -72.77 169.7 16.17 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.311 3.044 . . . . 0.0 116.548 176.394 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.0 126.62 41.37 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 104.27 -2.493 . . . . 0.0 104.27 -172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.379 6.3 m -123.9 147.82 28.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.633 -1.292 . . . . 0.0 111.878 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 125' ' ' LEU . 1.1 m -107.53 149.55 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 C-N-CA 127.248 2.219 . . . . 0.0 107.217 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.3 108.4 10.56 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 114.148 -166.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.24 115.13 11.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.431 2.692 . . . . 0.0 105.124 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -83.01 -31.32 27.53 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.334 3.243 . . . . 0.0 114.452 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -129.21 152.08 49.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.9 p -73.25 107.41 5.55 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 121.951 2.159 . . . . 0.0 109.374 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.41 -24.49 13.84 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 129.184 2.994 . . . . 0.0 114.078 -165.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.6 -18.26 29.91 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 127.482 2.468 . . . . 0.0 112.62 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -135.87 150.56 49.41 Favored 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.712 2.405 . . . . 0.0 112.474 171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.625 ' CG ' ' HG2' ' A' ' 17' ' ' LYS 0.265 0.0 OUTLIER -118.28 148.3 42.58 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.848 1.659 . . . . 0.0 106.574 175.352 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -98.39 -175.83 3.22 Favored 'General case' 0 C--N 1.353 0.733 1 C-N-CA 135.779 5.631 . . . . 0.0 105.088 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -137.21 160.88 37.74 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -139.83 166.5 25.63 Favored Glycine 0 C--N 1.365 2.181 1 C-N-CA 135.511 6.291 . . . . 0.0 121.013 -159.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 149.06 40.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.636 1.174 . . . . 0.0 109.775 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.4 155.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.368 1.385 0 O-C-N 118.572 -2.58 . . . . 0.0 114.484 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -119.48 -40.43 2.79 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.246 1.419 . . . . 0.0 111.363 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -145.34 160.96 40.73 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.18 143.14 27.06 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.869 168.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -117.96 129.33 74.51 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 177.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 14.96 -120.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.173 2 N-CA-C 123.863 4.305 . . . . 0.0 123.863 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.37 112.36 25.44 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.76 1.624 . . . . 0.0 110.45 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.64 1.77 89.34 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 126.383 1.944 . . . . 0.0 115.595 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.369 0.0 OUTLIER -103.39 153.55 20.36 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-O 124.252 1.977 . . . . 0.0 113.431 -175.844 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG23 ' A' ' 33' ' ' VAL . 37.3 m-85 -134.71 133.46 40.0 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.149 2.18 . . . . 0.0 110.345 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.25 102.8 11.44 Favored 'General case' 0 C--N 1.391 2.372 0 N-CA-C 101.011 -3.7 . . . . 0.0 101.011 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.08 167.38 21.36 Favored 'General case' 0 CA--C 1.476 -1.885 0 CA-C-N 110.382 -3.099 . . . . 0.0 117.008 -161.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.32 6.1 tt -128.83 152.39 48.55 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 119.912 -1.742 . . . . 0.0 108.585 167.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.484 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.8 m-30 -74.54 167.02 22.56 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 117.406 -3.309 . . . . 0.0 112.209 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.25 3.1 4.96 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.835 -3.041 . . . . 0.0 113.594 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -125.72 0.44 7.44 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 131.407 3.883 . . . . 0.0 114.733 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.696 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 106.38 6.89 35.59 Favored Glycine 0 C--N 1.379 2.962 0 N-CA-C 119.961 2.744 . . . . 0.0 119.961 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -93.84 103.76 15.86 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 120.162 1.981 . . . . 0.0 110.135 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -96.24 149.24 21.87 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.82 178.06 7.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -174.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.257 1.3 m-20 -125.14 137.08 54.16 Favored 'General case' 0 C--N 1.356 0.849 1 N-CA-C 98.073 -4.788 . . . . 0.0 98.073 163.693 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 m -147.9 166.59 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-N 118.896 0.771 . . . . 0.0 109.609 -176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.07 136.55 33.97 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 125.061 1.345 . . . . 0.0 107.514 168.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . . . -71.34 -24.8 76.52 Favored Glycine 0 CA--C 1.487 -1.693 0 N-CA-C 117.371 1.708 . . . . 0.0 117.371 -152.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -3.32 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.201 2.5 . . . . 0.0 115.796 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.04 -78.3 0.56 Allowed 'General case' 0 C--N 1.36 1.049 1 C-N-CA 135.233 5.413 . . . . 0.0 108.367 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -114.47 100.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.345 0 O-C-N 117.365 -3.334 . . . . 0.0 111.276 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.804 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.4 pp -135.08 161.73 34.48 Favored 'General case' 0 C--N 1.374 1.641 1 N-CA-C 122.325 4.194 . . . . 0.0 122.325 -168.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HB2' HD11 ' A' ' 12' ' ' LEU 0.266 0.0 OUTLIER -48.75 102.85 0.04 OUTLIER 'General case' 0 C--N 1.38 1.912 1 C-N-CA 134.733 5.213 . . . . 0.0 115.647 168.943 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.38 174.64 7.62 Favored 'General case' 0 N--CA 1.399 -2.986 0 C-N-CA 128.564 2.746 . . . . 0.0 111.634 -172.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.06 -34.69 0.15 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 130.429 3.492 . . . . 0.0 112.91 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 14.7 Cg_endo -71.76 -73.99 0.0 OUTLIER 'Cis proline' 0 C--N 1.379 2.167 0 CA-C-N 127.894 3.855 . . . . 0.0 113.004 5.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.882 HD12 HD13 ' A' ' 119' ' ' LEU 0.363 0.4 OUTLIER -114.28 160.05 34.22 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 -171.436 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 69.1 Cg_exo -64.29 134.7 43.23 Favored 'Trans proline' 0 CA--C 1.549 1.231 1 C-N-CA 125.789 4.326 . . . . 0.0 117.649 -152.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.281 1.4 mp -39.07 15.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 2 C-N-CA 134.8 5.24 . . . . 0.0 125.024 178.72 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.446 10.1 m-20 -142.3 20.86 2.07 Favored 'General case' 0 N--CA 1.436 -1.14 1 C-N-CA 133.483 4.713 . . . . 0.0 109.295 -173.336 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.565 HG21 ' CG2' ' A' ' 61' ' ' ILE 0.325 92.4 m -115.14 112.24 22.25 Favored 'General case' 0 CA--C 1.438 -3.36 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -159.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.5 95.32 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 124.299 1.999 . . . . 0.0 111.829 161.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.736 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -98.71 170.78 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -1.987 1 C-N-CA 133.24 4.616 . . . . 0.0 104.643 -179.958 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.05 133.93 38.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.13 140.95 33.63 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 120.132 -1.605 . . . . 0.0 108.863 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 99.62 0.45 Allowed 'General case' 0 C--N 1.361 1.077 0 CA-C-O 126.628 3.109 . . . . 0.0 116.734 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 m -137.48 168.84 18.85 Favored 'General case' 0 N--CA 1.427 -1.598 3 C-N-CA 136.757 6.023 . . . . 0.0 98.577 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.6 pm0 -37.73 156.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -48.67 -51.14 29.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 120.557 3.54 . . . . 0.0 120.557 -164.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -110.75 -8.68 14.54 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.909 1.284 . . . . 0.0 109.544 171.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -110.16 4.68 21.29 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -163.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.13 158.67 2.83 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 129.201 3.0 . . . . 0.0 118.496 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m -140.52 160.25 40.41 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 119.594 -1.941 . . . . 0.0 113.376 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.334 . . -79.06 150.53 31.84 Favored 'General case' 0 C--N 1.365 1.27 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -172.727 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.45 161.31 30.44 Favored Glycine 0 C--N 1.367 2.255 0 N-CA-C 103.651 -3.78 . . . . 0.0 103.651 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.2 t -104.39 124.33 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 116.42 2.008 . . . . 0.0 116.42 -162.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -67.66 125.63 25.66 Favored 'Isoleucine or valine' 0 C--N 1.382 1.998 0 CA-C-N 120.696 1.589 . . . . 0.0 111.357 163.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.61 -47.36 1.7 Allowed 'General case' 0 C--N 1.375 1.706 0 O-C-N 124.619 1.2 . . . . 0.0 111.987 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.16 143.52 12.27 Favored Glycine 0 C--N 1.363 2.064 0 O-C-N 119.817 -1.802 . . . . 0.0 111.687 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -138.07 149.28 45.84 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 161.87 36.88 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.14 -174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.27 24.9 pttm -137.68 148.4 45.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.919 161.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -117.96 161.41 19.83 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 128.41 2.684 . . . . 0.0 106.026 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -59.03 64.83 0.0 OUTLIER 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.495 2.318 . . . . 0.0 116.908 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.13 13.85 8.14 Favored Glycine 0 C--N 1.356 1.651 0 C-N-CA 127.397 2.427 . . . . 0.0 112.741 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -139.9 147.84 41.17 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.38 129.63 37.67 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.453 3.8 p90 -145.72 136.23 24.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 123.456 2.844 . . . . 0.0 112.228 169.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 84' ' ' HIS . 6.4 m-85 -107.82 128.8 54.92 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.813 2.845 . . . . 0.0 106.12 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.3 p -90.64 101.9 14.64 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-O 124.307 2.003 . . . . 0.0 107.057 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 93' ' ' TYR . 41.9 mm -100.96 116.58 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.239 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . 0.297 5.4 tm-20 -87.74 107.6 18.72 Favored 'General case' 0 C--N 1.362 1.115 0 CA-C-O 122.77 1.272 . . . . 0.0 110.695 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -143.81 132.78 22.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.077 -163.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 67.79 3.25 3.39 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 127.55 2.34 . . . . 0.0 113.628 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.02 -5.23 13.71 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 127.064 2.268 . . . . 0.0 112.074 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.54 HE22 ' CD ' ' A' ' 102' ' ' LYS . 1.1 pp0? -137.12 170.54 15.92 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 124.239 1.016 . . . . 0.0 111.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 101' ' ' ARG 0.264 0.0 OUTLIER -93.93 123.19 37.13 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 119.606 -1.934 . . . . 0.0 113.751 -175.405 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.54 ' CD ' HE22 ' A' ' 100' ' ' GLN . 5.9 mptp? -94.57 126.12 39.66 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -101.07 107.45 18.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -129.3 138.7 51.75 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 124.566 1.146 . . . . 0.0 112.913 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -60.7 145.63 48.69 Favored 'General case' 0 C--N 1.376 1.718 0 O-C-N 120.135 -1.603 . . . . 0.0 109.732 157.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 44.0 mmm-85 -30.1 -41.17 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 131.124 3.77 . . . . 0.0 120.665 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.54 -22.31 66.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.434 3.093 . . . . 0.0 115.347 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.5 58.67 Favored 'General case' 0 C--N 1.379 1.875 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.38 95.83 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 130.109 3.364 . . . . 0.0 112.824 174.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -101.27 -176.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 119.862 -1.774 . . . . 0.0 112.967 178.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.583 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -147.26 164.15 34.14 Favored 'General case' 0 C--N 1.368 1.373 0 O-C-N 120.32 -1.488 . . . . 0.0 113.984 -178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 t -104.22 165.6 10.95 Favored 'General case' 0 C--N 1.371 1.5 0 C-N-CA 126.252 1.821 . . . . 0.0 109.479 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.447 2.4 mt -57.53 -49.64 75.67 Favored 'General case' 0 C--N 1.385 2.112 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.68 2.8 mt-10 -67.42 -10.59 52.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.736 HE22 ' HA ' ' A' ' 67' ' ' VAL . 43.0 mt-30 -78.36 -31.03 48.31 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.321 1.448 . . . . 0.0 110.416 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -76.84 -55.25 4.56 Favored Glycine 0 C--N 1.354 1.569 1 C-N-CA 133.352 5.263 . . . . 0.0 111.774 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 28.2 m120 -67.64 -27.08 66.58 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 127.923 2.489 . . . . 0.0 115.109 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -32.43 72.2 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.567 1.147 . . . . 0.0 112.59 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.882 HD13 HD12 ' A' ' 61' ' ' ILE . 2.4 tt -89.81 -41.72 11.68 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 131.302 3.841 . . . . 0.0 110.015 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 117' ' ' ASN 0.27 0.0 OUTLIER -36.59 -40.18 0.24 Allowed 'General case' 0 C--N 1.363 1.181 0 N-CA-C 120.826 3.639 . . . . 0.0 120.826 -167.552 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.76 -18.01 24.54 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.305 2.242 . . . . 0.0 113.428 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -103.05 -45.84 4.82 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.671 1.989 . . . . 0.0 113.62 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -131.31 11.15 4.94 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 118.707 2.854 . . . . 0.0 118.707 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.59 -76.58 0.1 Allowed Glycine 0 CA--C 1.462 -3.225 0 C-N-CA 114.253 -3.832 . . . . 0.0 107.931 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.804 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.546 2.5 mm? -49.04 13.95 0.0 OUTLIER 'General case' 0 C--N 1.373 1.623 0 N-CA-C 121.798 3.999 . . . . 0.0 121.798 -167.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.12 96.34 0.1 Allowed Glycine 0 C--N 1.356 1.686 0 CA-C-O 117.06 -1.967 . . . . 0.0 115.149 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.9 -32.0 0.36 Allowed 'Trans proline' 0 CA--C 1.551 1.373 1 CA-C-N 125.41 4.605 . . . . 0.0 111.957 174.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.42 147.9 43.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 129.951 3.301 . . . . 0.0 107.595 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 110.695 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.019 0.438 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 p -74.89 -55.44 5.8 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 127.726 2.41 . . . . 0.0 113.766 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 12' ' ' LEU . 23.8 m-85 -94.26 -8.89 37.84 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 124.801 1.24 . . . . 0.0 113.199 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 10' ' ' VAL 0.372 0.8 OUTLIER -69.13 -3.45 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.368 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.57 41.33 1.4 Allowed Glycine 0 C--N 1.365 2.173 0 O-C-N 119.978 -1.701 . . . . 0.0 109.776 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 57' ' ' LEU . 11.8 tp -84.28 162.32 20.15 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.485 1.914 . . . . 0.0 114.763 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -111.02 112.72 24.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 128.597 2.759 . . . . 0.0 105.934 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 HG12 ' A' ' 29' ' ' ILE . 15.4 m -130.27 163.92 34.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 CA-C-O 123.839 1.781 . . . . 0.0 113.944 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD21 ' A' ' 111' ' ' LEU . 4.1 m -126.63 156.65 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.59 107.65 10.8 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -161.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -123.28 135.23 54.14 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 107.096 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -90.35 -54.32 4.06 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 118.08 -2.887 . . . . 0.0 114.386 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -128.37 151.74 48.99 Favored 'General case' 0 CA--C 1.506 -0.729 1 N-CA-C 98.673 -4.565 . . . . 0.0 98.673 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -59.33 108.84 0.76 Allowed 'General case' 0 C--N 1.363 1.175 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -99.11 -32.03 11.46 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 118.709 2.855 . . . . 0.0 118.709 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.23 36.18 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 126.737 2.113 . . . . 0.0 111.346 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.553 0.8 OUTLIER -137.43 150.97 48.03 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 128.187 2.595 . . . . 0.0 115.113 162.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CG ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.09 143.25 46.6 Favored 'General case' 0 C--N 1.366 1.309 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.76 -172.0 2.75 Favored 'General case' 0 C--O 1.22 -0.498 1 C-N-CA 137.025 6.13 . . . . 0.0 109.418 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -104.66 129.46 52.82 Favored 'General case' 0 CA--C 1.558 1.282 1 N-CA-C 122.122 4.119 . . . . 0.0 122.122 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.57 163.94 26.06 Favored Glycine 0 C--N 1.372 2.555 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -130.86 144.74 51.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.097 -1.825 . . . . 0.0 112.697 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 12' ' ' LEU . 35.0 mm -99.03 143.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.392 2.418 0 CA-C-N 122.622 2.465 . . . . 0.0 114.775 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -119.4 -22.63 6.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.725 1.61 . . . . 0.0 111.487 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -158.58 163.91 36.56 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.4 139.84 39.42 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 119.251 -2.156 . . . . 0.0 109.2 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.99 124.66 62.88 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 178.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 19.85 -119.48 0.01 OUTLIER Glycine 0 C--N 1.358 1.791 2 C-N-CA 131.045 4.165 . . . . 0.0 123.301 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.41 112.37 25.45 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.72 2.008 . . . . 0.0 111.136 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.93 25.15 62.8 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 125.767 1.651 . . . . 0.0 115.383 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.364 0.2 OUTLIER -133.28 161.66 33.88 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 122.787 1.28 . . . . 0.0 112.416 -178.69 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 45.3 m-85 -138.15 137.58 37.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 130.29 3.436 . . . . 0.0 111.185 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -103.56 115.57 30.76 Favored 'General case' 0 C--N 1.385 2.138 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -130.74 156.94 44.11 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.854 -163.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.419 9.3 tt -129.31 144.47 51.24 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 168.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.1 149.83 42.76 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.108 -2.87 . . . . 0.0 108.373 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.251 8.9 p-10 -61.17 -7.72 2.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 119.258 -2.151 . . . . 0.0 116.696 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.22 -0.95 24.1 Favored 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 131.902 4.081 . . . . 0.0 113.64 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.32 16.58 15.88 Favored Glycine 0 C--N 1.374 2.675 0 N-CA-C 120.944 3.138 . . . . 0.0 120.944 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -99.71 107.15 19.16 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 120.58 2.19 . . . . 0.0 109.621 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HB2' HD12 ' A' ' 41' ' ' LEU . 14.5 tt0 -91.97 153.54 19.39 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.26 178.64 9.03 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.285 1.8 m-20 -125.47 129.93 50.78 Favored 'General case' 0 CA--C 1.488 -1.419 1 N-CA-C 95.802 -5.629 . . . . 0.0 95.802 165.67 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 55' ' ' ILE . 2.4 p -148.35 169.15 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.401 -168.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.08 155.86 32.14 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.02 1.69 68.13 Favored Glycine 0 C--N 1.359 1.813 0 C-N-CA 126.823 2.154 . . . . 0.0 116.008 -161.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 17.5 20.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.786 2.834 . . . . 0.0 105.571 172.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -134.66 -76.88 0.46 Allowed 'General case' 0 C--N 1.364 1.224 0 C-N-CA 128.066 2.547 . . . . 0.0 109.312 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -113.16 100.9 11.66 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.598 HD11 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.35 158.8 42.88 Favored 'General case' 0 CA--C 1.47 -2.118 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 -163.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -52.89 101.12 0.03 OUTLIER 'General case' 0 C--N 1.397 2.635 1 C-N-CA 132.478 4.311 . . . . 0.0 109.64 169.617 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.283 1.3 t -123.34 175.13 6.89 Favored 'General case' 0 N--CA 1.396 -3.145 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 -170.694 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.71 -44.03 15.91 Favored Pre-proline 0 CA--C 1.588 2.431 0 O-C-N 119.519 -1.988 . . . . 0.0 110.314 164.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 15' ' ' VAL 0.319 10.9 Cg_endo -60.6 -64.76 0.03 OUTLIER 'Cis proline' 0 CA--C 1.457 -3.343 0 CA-C-N 123.901 2.429 . . . . 0.0 116.6 5.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 111' ' ' LEU . 11.3 mm -126.02 160.45 56.9 Favored Pre-proline 0 CA--C 1.486 -1.483 0 CA-C-N 123.103 2.683 . . . . 0.0 108.042 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 61' ' ' ILE 0.384 20.5 Cg_exo -51.72 105.34 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.727 4.285 . . . . 0.0 116.623 -167.788 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HA ' HG23 ' A' ' 81' ' ' VAL 0.677 0.0 OUTLIER -40.04 15.13 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 2 N-CA-C 124.429 4.974 . . . . 0.0 124.429 -176.322 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.463 2.5 m-20 -132.62 -11.13 3.12 Favored 'General case' 0 C--N 1.311 -1.101 1 C-N-CA 132.434 4.294 . . . . 0.0 115.519 -174.777 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.0 m -118.35 155.33 30.86 Favored 'General case' 0 CA--C 1.437 -3.368 0 C-N-CA 128.031 2.532 . . . . 0.0 113.522 -153.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.47 125.84 25.22 Favored 'General case' 0 N--CA 1.434 -1.235 1 C-N-CA 133.635 4.774 . . . . 0.0 109.182 171.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 81' ' ' VAL 0.35 0.0 OUTLIER -158.94 174.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.81 1 C-N-CA 131.842 4.057 . . . . 0.0 105.331 -175.908 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -114.16 158.29 21.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.922 1.344 . . . . 0.0 112.215 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.18 139.95 38.0 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.763 1.625 . . . . 0.0 107.752 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.49 HD23 HG12 ' A' ' 110' ' ' ILE 0.371 0.1 OUTLIER -97.42 109.64 22.35 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 124.705 2.193 . . . . 0.0 113.735 -174.96 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t -137.84 167.74 21.12 Favored 'General case' 0 N--CA 1.433 -1.287 2 N-CA-C 95.899 -5.593 . . . . 0.0 95.899 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.7 pm0 -39.17 153.75 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.315 1 N-CA-C 121.808 4.003 . . . . 0.0 121.808 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.87 -50.3 10.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 121.728 3.973 . . . . 0.0 121.728 -167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.2 6.77 20.89 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 126.874 2.069 . . . . 0.0 111.456 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -109.96 -26.4 9.77 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.763 1.225 . . . . 0.0 112.429 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.96 163.77 0.71 Allowed 'General case' 0 C--N 1.366 1.324 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.7 m -140.47 150.83 44.27 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 120.356 -1.465 . . . . 0.0 109.818 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.16 160.85 25.53 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.17 -167.05 20.19 Favored Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 128.418 2.913 . . . . 0.0 110.017 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.91 140.18 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.762 0 O-C-N 121.063 -1.257 . . . . 0.0 108.041 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 63' ' ' LEU . 28.4 m -81.74 129.77 36.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 166.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -126.67 1.1 6.8 Favored 'General case' 0 C--N 1.363 1.171 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.29 151.7 6.75 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.6 p80 -152.1 166.54 31.32 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.24 161.54 36.03 Favored 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.126 0.489 . . . . 0.0 110.438 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.347 19.7 ptpt -137.89 145.62 42.36 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 120.423 -1.423 . . . . 0.0 107.631 159.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -128.25 161.37 29.51 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 p -59.71 77.48 0.01 OUTLIER 'General case' 0 C--N 1.359 1.009 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.91 3.92 23.03 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 126.811 2.148 . . . . 0.0 113.152 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -132.29 140.76 48.72 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 119.188 1.494 . . . . 0.0 107.89 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -133.46 122.9 24.33 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.42 1.9 p90 -145.12 132.89 21.08 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 124.443 3.292 . . . . 0.0 112.475 171.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -104.52 142.58 34.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.861 2.465 . . . . 0.0 105.726 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.5 t -103.89 122.35 44.99 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.944 1.698 . . . . 0.0 110.241 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.7 mp -118.67 113.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.87 112.61 22.69 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -144.32 129.17 18.37 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -159.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.27 3.69 2.35 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.547 1.939 . . . . 0.0 115.009 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -11.0 10.89 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 126.846 2.165 . . . . 0.0 111.813 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.94 171.26 12.5 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 111.927 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -93.89 140.53 29.58 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.788 -1.82 . . . . 0.0 115.056 -177.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -127.81 131.49 49.55 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -124.34 109.94 13.96 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.195 -1.565 . . . . 0.0 108.02 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -129.57 152.47 49.06 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.341 1.857 . . . . 0.0 112.132 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.24 161.7 6.8 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 126.642 1.977 . . . . 0.0 110.26 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -32.19 -35.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -55.92 -31.13 62.62 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 131.823 4.049 . . . . 0.0 117.074 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.86 12.86 19.56 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.493 1.497 . . . . 0.0 114.869 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 93' ' ' TYR 0.28 10.5 p -126.47 105.09 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 126.962 2.105 . . . . 0.0 109.344 175.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.49 HG12 HD23 ' A' ' 70' ' ' LEU . 1.8 pp -128.46 -170.45 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.332 0 O-C-N 120.156 -1.59 . . . . 0.0 113.009 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.61 156.68 42.74 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 -176.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.4 p -102.8 166.49 10.45 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 127.538 2.335 . . . . 0.0 108.657 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.559 0.0 OUTLIER -63.74 -28.5 69.92 Favored 'General case' 0 C--N 1.386 2.178 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.614 3.3 mt-10 -85.48 -10.69 55.74 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 124.813 3.461 . . . . 0.0 116.219 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.617 ' O ' HD12 ' A' ' 61' ' ' ILE . 33.0 mt-30 -89.22 -23.77 22.28 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 128.091 2.556 . . . . 0.0 112.127 169.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.37 -44.54 4.31 Favored Glycine 0 C--N 1.364 2.105 1 C-N-CA 131.34 4.305 . . . . 0.0 116.887 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -75.78 -17.44 59.87 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.12 -2.4 . . . . 0.0 112.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.04 -22.21 55.96 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.866 1.666 . . . . 0.0 110.871 173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -91.19 -45.61 8.55 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 130.041 3.336 . . . . 0.0 107.613 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -43.41 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -175.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.5 -18.08 27.39 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.507 2.323 . . . . 0.0 114.131 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -105.31 -45.47 4.47 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.495 1.918 . . . . 0.0 114.469 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.338 8.1 m-85 -131.13 17.19 5.04 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-O 115.951 -1.976 . . . . 0.0 116.122 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 57' ' ' LEU . . . 159.72 -48.69 0.4 Allowed Glycine 0 CA--C 1.456 -3.65 1 C-N-CA 112.847 -4.501 . . . . 0.0 114.934 173.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.598 ' HG ' HD11 ' A' ' 56' ' ' LEU 0.454 0.2 OUTLIER -68.67 13.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 120.143 3.386 . . . . 0.0 120.143 -167.468 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.48 90.77 0.11 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-O 117.058 -1.968 . . . . 0.0 113.945 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.47 -26.1 1.44 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.075 3.937 . . . . 0.0 111.618 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.69 131.08 57.04 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 129.483 3.113 . . . . 0.0 106.982 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.354 0.764 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.323 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 p -101.76 -55.9 2.4 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.981 2.112 . . . . 0.0 114.408 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HB3' HD12 ' A' ' 12' ' ' LEU . 98.2 m-85 -94.68 30.5 2.02 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 126.891 2.076 . . . . 0.0 115.25 -174.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 10' ' ' VAL . 10.1 t -52.0 -30.97 13.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 130.098 3.359 . . . . 0.0 118.15 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.64 40.83 1.72 Allowed Glycine 0 C--N 1.354 1.571 0 C-N-CA 126.354 1.931 . . . . 0.0 112.848 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD11 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -77.74 164.22 25.45 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 127.534 2.334 . . . . 0.0 108.85 173.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -119.54 130.47 55.19 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 129.679 3.191 . . . . 0.0 107.256 -170.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 29' ' ' ILE 0.253 4.6 m -130.81 166.23 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 124.818 2.247 . . . . 0.0 116.446 -172.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 56' ' ' LEU . 2.7 m -126.3 148.61 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -117.01 107.48 14.59 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -129.01 95.22 4.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 120.635 -1.29 . . . . 0.0 108.375 176.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CH2' HG12 ' A' ' 50' ' ' VAL . 72.3 m95 -67.29 -42.92 82.95 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 123.79 2.995 . . . . 0.0 112.527 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -129.23 146.97 51.04 Favored 'General case' 0 C--N 1.348 0.526 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 163.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -69.57 126.14 28.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.558 1.943 . . . . 0.0 111.621 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -12.13 17.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -170.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.54 -19.71 28.46 Favored Glycine 0 CA--C 1.5 -0.896 0 C-N-CA 127.781 2.61 . . . . 0.0 107.682 -163.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -136.5 166.9 22.42 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 130.315 3.446 . . . . 0.0 114.356 170.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.751 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.48 150.09 40.17 Favored 'General case' 0 C--N 1.376 1.727 0 C-N-CA 130.105 3.362 . . . . 0.0 104.774 171.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -92.83 -173.0 3.18 Favored 'General case' 0 CA--C 1.546 0.818 1 C-N-CA 135.166 5.386 . . . . 0.0 109.315 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . 0.259 1.2 t -110.6 122.65 48.3 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 120.118 3.377 . . . . 0.0 120.118 -169.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.19 165.1 25.78 Favored Glycine 0 C--N 1.375 2.75 0 N-CA-C 118.542 2.177 . . . . 0.0 118.542 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -121.88 144.34 48.9 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 126.935 2.094 . . . . 0.0 111.964 172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 12' ' ' LEU . 10.0 mm -87.74 152.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.392 2.452 0 CA-C-N 124.893 3.497 . . . . 0.0 112.813 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.3 m -114.56 -40.29 3.63 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.367 1.867 . . . . 0.0 109.183 171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -156.83 172.04 19.34 Favored 'General case' 0 C--N 1.373 1.626 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.57 157.1 16.05 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.19 -2.194 . . . . 0.0 109.543 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -121.15 120.99 63.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.33 -134.81 6.38 Favored Glycine 0 C--N 1.358 1.779 0 C-N-CA 128.591 2.996 . . . . 0.0 119.354 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.49 123.29 47.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 127.056 2.142 . . . . 0.0 106.941 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.68 67.6 Favored Glycine 0 CA--C 1.493 -1.29 0 CA-C-O 117.145 -1.919 . . . . 0.0 114.702 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.712 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.0 mttt -117.71 166.12 12.81 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 121.609 2.704 . . . . 0.0 112.49 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CE2' HD12 ' A' ' 57' ' ' LEU . 61.7 m-85 -135.74 148.43 48.82 Favored 'General case' 0 C--N 1.37 1.481 0 C-N-CA 127.76 2.424 . . . . 0.0 112.278 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -115.61 109.91 18.43 Favored 'General case' 0 C--N 1.381 1.964 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 157.16 46.89 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 111.337 -2.665 . . . . 0.0 115.765 -163.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 47' ' ' GLU 0.339 10.1 tt -130.32 138.71 50.59 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.702 -1.874 . . . . 0.0 107.728 173.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.19 148.93 45.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 118.634 -2.541 . . . . 0.0 109.111 173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.8 -19.15 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 127.589 2.356 . . . . 0.0 116.954 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.21 -4.16 36.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 131.105 3.762 . . . . 0.0 113.906 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 18.77 15.87 Favored Glycine 0 C--N 1.378 2.863 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 167.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -94.79 106.61 18.6 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 119.815 1.808 . . . . 0.0 107.963 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' CG ' ' A' ' 41' ' ' LEU 0.275 4.8 tm-20 -103.8 151.68 22.78 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 120.269 -1.52 . . . . 0.0 113.947 177.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.84 177.83 6.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -170.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -124.41 140.16 53.21 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 100.421 -3.918 . . . . 0.0 100.421 165.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 55' ' ' ILE . 30.9 m -147.68 167.08 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 C-N-CA 123.385 0.674 . . . . 0.0 110.492 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -81.16 151.08 28.4 Favored 'General case' 0 C--N 1.37 1.464 0 CA-C-O 123.254 1.502 . . . . 0.0 113.107 175.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -82.88 5.13 77.09 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 -157.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.98 10.03 30.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.539 1.535 . . . . 0.0 107.513 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.14 -82.22 0.63 Allowed 'General case' 0 C--N 1.368 1.381 0 C-N-CA 126.359 1.864 . . . . 0.0 109.685 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -114.38 99.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 118.319 -2.738 . . . . 0.0 103.757 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.0 157.96 44.73 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -159.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.934 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.48 101.73 0.04 OUTLIER 'General case' 0 C--N 1.379 1.879 1 C-N-CA 132.119 4.168 . . . . 0.0 116.71 172.962 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.344 0.1 OUTLIER -124.76 174.61 7.79 Favored 'General case' 0 N--CA 1.391 -3.424 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -174.968 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 6.7 t0 -70.99 -46.16 14.92 Favored Pre-proline 0 CA--C 1.557 1.223 1 C-N-CA 131.745 4.018 . . . . 0.0 106.291 166.11 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 58' ' ' CYS 0.376 1.0 OUTLIER -54.54 -75.22 0.0 OUTLIER 'Cis proline' 0 CA--C 1.459 -3.257 0 CA-C-N 123.694 2.355 . . . . 0.0 116.655 -0.297 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 119' ' ' LEU 0.273 0.4 OUTLIER -125.72 159.0 63.18 Favored Pre-proline 0 CA--C 1.512 -0.483 0 CA-C-N 122.011 2.187 . . . . 0.0 113.712 -167.595 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 61' ' ' ILE . 52.8 Cg_exo -53.58 120.75 8.33 Favored 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.98 5.786 . . . . 0.0 115.702 -167.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 4.4 mp -40.95 13.99 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 1 C-N-CA 139.702 7.201 . . . . 0.0 121.659 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' PRO 0.411 19.8 m-20 -138.48 17.99 2.73 Favored 'General case' 0 C--N 1.306 -1.293 1 C-N-CA 136.021 5.728 . . . . 0.0 112.039 -175.191 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.582 ' HB ' HG12 ' A' ' 81' ' ' VAL . 71.6 m -114.76 114.72 25.97 Favored 'General case' 0 CA--C 1.435 -3.461 0 CA-C-N 120.376 1.443 . . . . 0.0 113.996 -162.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.0 92.76 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 122.184 0.992 . . . . 0.0 110.585 164.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -98.9 172.33 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.471 -2.061 0 C-N-CA 130.873 3.669 . . . . 0.0 105.602 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -98.98 139.02 35.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.38 140.66 39.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 110.634 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.77 106.88 1.62 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-O 126.897 3.237 . . . . 0.0 119.698 -172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.5 m -139.58 168.87 18.84 Favored 'General case' 0 N--CA 1.435 -1.191 1 C-N-CA 133.654 4.782 . . . . 0.0 100.263 171.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.5 pm0 -38.53 159.23 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 121.094 3.738 . . . . 0.0 121.094 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -44.8 -50.24 10.29 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 120.956 3.687 . . . . 0.0 120.956 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -110.67 3.75 19.52 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.328 1.051 . . . . 0.0 110.084 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -116.37 -14.96 10.99 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -164.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.38 155.2 4.01 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 t -138.12 159.53 41.78 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 120.683 -1.26 . . . . 0.0 111.215 -166.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 67' ' ' VAL 0.268 . . -84.35 150.97 25.02 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.98 162.89 32.94 Favored Glycine 0 C--N 1.363 2.073 0 N-CA-C 104.394 -3.483 . . . . 0.0 104.394 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -101.58 118.08 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.083 0 CA-C-N 118.646 1.223 . . . . 0.0 114.158 -163.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 65' ' ' THR . 7.0 p -69.24 133.34 32.02 Favored 'Isoleucine or valine' 0 C--N 1.369 1.445 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.311 171.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' HH12 ' A' ' 101' ' ' ARG . 68.8 mttm -135.34 -41.41 0.72 Allowed 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.793 1.308 . . . . 0.0 113.14 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.08 137.9 8.96 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 1.8 p-80 -152.12 166.51 31.44 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 118.673 -2.663 . . . . 0.0 112.331 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.16 163.99 38.93 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -137.46 138.58 39.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.64 160.59 22.2 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 m -58.87 66.07 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.06 4.14 18.88 Favored Glycine 0 C--N 1.356 1.662 0 C-N-CA 127.097 2.284 . . . . 0.0 113.709 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -127.4 138.6 53.03 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.77 136.45 54.43 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.96 121.54 24.12 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 115.698 -2.401 . . . . 0.0 105.891 165.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 1.7 t80 -120.0 118.05 29.65 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 t -99.25 125.94 44.96 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 127.182 2.193 . . . . 0.0 112.585 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -125.93 132.09 71.06 Favored 'Isoleucine or valine' 0 C--N 1.373 1.597 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -174.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.62 118.52 36.33 Favored 'General case' 0 C--N 1.369 1.442 0 C-N-CA 123.711 0.805 . . . . 0.0 109.688 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -144.57 134.37 23.69 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -167.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 66.36 3.57 2.86 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 126.893 2.077 . . . . 0.0 114.666 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.4 -11.1 23.99 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 127.192 2.33 . . . . 0.0 110.189 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -117.13 170.32 8.75 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 125.147 1.379 . . . . 0.0 113.035 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.547 HH12 ' HB2' ' A' ' 82' ' ' LYS . 14.2 tpp180 -96.71 141.61 29.73 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.331 -1.481 . . . . 0.0 111.207 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -121.27 120.27 34.66 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.78 121.28 44.66 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.422 ' HD2' HD11 ' A' ' 95' ' ' ILE . 34.2 m-85 -129.1 176.22 8.07 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.916 2.486 . . . . 0.0 107.633 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -101.88 156.01 17.79 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 97.927 -4.842 . . . . 0.0 97.927 160.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -31.7 -34.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.652 3.204 . . . . 0.0 119.652 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . 0.328 18.2 ptm -65.3 -19.58 66.02 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -103.12 6.95 38.8 Favored 'General case' 0 C--N 1.379 1.864 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -126.03 122.3 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 C-N-CA 129.164 2.986 . . . . 0.0 106.574 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -177.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 119.789 -1.819 . . . . 0.0 111.707 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -148.24 150.39 33.61 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 120.382 -1.449 . . . . 0.0 114.48 -178.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.7 p -88.73 164.01 15.48 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 130.991 3.717 . . . . 0.0 112.736 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.681 0.0 OUTLIER -66.45 -39.46 88.88 Favored 'General case' 0 C--N 1.396 2.619 0 O-C-N 117.935 -2.978 . . . . 0.0 115.502 178.264 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.572 3.7 mt-10 -78.92 -11.3 60.0 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 125.68 3.855 . . . . 0.0 117.209 177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -91.64 -13.93 31.0 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 120.294 -1.504 . . . . 0.0 111.93 166.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' A' ' 61' ' ' ILE . . . -95.28 -45.93 2.91 Favored Glycine 0 C--N 1.362 1.996 0 C-N-CA 130.6 3.952 . . . . 0.0 118.283 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.69 -14.02 60.33 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.56 2.744 . . . . 0.0 112.763 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.96 -20.77 59.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.588 1.955 . . . . 0.0 110.733 172.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 61' ' ' ILE . 7.1 tt -92.57 -39.1 11.54 Favored 'General case' 0 C--N 1.377 1.793 0 C-N-CA 131.122 3.769 . . . . 0.0 109.556 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' A' ' 125' ' ' LEU . 6.8 ptm180 -47.61 -34.63 8.12 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 121.212 3.782 . . . . 0.0 121.212 -168.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.19 -17.23 22.93 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 128.552 2.741 . . . . 0.0 113.395 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -105.11 -44.32 4.81 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.604 1.162 . . . . 0.0 112.419 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -128.29 0.71 5.73 Favored 'General case' 0 C--N 1.368 1.389 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.83 -59.69 0.25 Allowed Glycine 0 C--N 1.376 2.776 0 C-N-CA 113.905 -3.997 . . . . 0.0 111.529 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HB3' ' CB ' ' A' ' 120' ' ' ARG 0.462 0.2 OUTLIER -50.96 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 -171.998 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.67 92.99 0.12 Allowed Glycine 0 C--N 1.361 1.971 0 CA-C-O 116.808 -2.107 . . . . 0.0 116.923 172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -96.07 20.66 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.056 1 CA-C-N 125.653 4.727 . . . . 0.0 112.776 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -104.02 119.26 38.56 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 121.284 1.856 . . . . 0.0 112.729 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.36 1.04 0 C-N-CA 126.311 1.844 . . . . 0.0 112.015 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.441 -0.887 0 CA-C-O 121.645 0.736 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -133.37 -105.36 0.24 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.065 1.346 . . . . 0.0 111.157 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD2' HD13 ' A' ' 12' ' ' LEU 0.329 50.3 p90 -125.27 35.83 4.69 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 125.912 1.685 . . . . 0.0 111.205 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.307 1.0 OUTLIER -77.0 6.24 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 170.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.73 25.81 4.65 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 129.418 3.389 . . . . 0.0 110.051 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.0 HD22 ' HB2' ' A' ' 57' ' ' LEU 0.421 1.4 tt -81.64 168.77 17.79 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 131.508 3.923 . . . . 0.0 110.395 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.637 ' N ' HD23 ' A' ' 12' ' ' LEU . 4.8 mmp_? -96.11 138.39 33.8 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.665 2.786 . . . . 0.0 110.517 -162.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 HG21 ' HB ' ' A' ' 29' ' ' ILE . 12.8 t -130.58 163.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -161.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.01 144.05 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.815 2.446 . . . . 0.0 106.805 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -125.97 107.18 10.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.662 1.985 . . . . 0.0 111.384 -167.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.61 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.17 115.68 11.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.948 2.899 . . . . 0.0 107.231 -176.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.87 -38.07 18.47 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 123.376 2.807 . . . . 0.0 116.311 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.0 m -128.37 151.96 48.74 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 101.516 -3.512 . . . . 0.0 101.516 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -73.66 107.48 5.94 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 122.052 2.205 . . . . 0.0 110.581 174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.269 15.9 t-20 -105.37 -25.59 12.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 130.589 3.556 . . . . 0.0 113.119 -168.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 113' ' ' LEU . . . 109.99 -18.68 28.56 Favored Glycine 0 CA--C 1.477 -2.286 0 C-N-CA 127.851 2.643 . . . . 0.0 113.776 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.524 0.1 OUTLIER -136.5 146.46 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 121.473 2.637 . . . . 0.0 114.968 168.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.61 ' CG ' ' HG2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.49 146.35 38.62 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 128.038 2.535 . . . . 0.0 105.617 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -100.05 -174.29 2.65 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 133.564 4.746 . . . . 0.0 106.637 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.6 p -98.15 139.37 34.04 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 121.006 3.706 . . . . 0.0 121.006 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' C ' ' HB ' ' A' ' 14' ' ' VAL . . . -139.71 166.89 25.5 Favored Glycine 0 C--N 1.36 1.897 0 C-N-CA 130.038 3.685 . . . . 0.0 112.027 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -128.35 140.62 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 121.801 2.8 . . . . 0.0 108.932 168.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 14' ' ' VAL . 1.2 tp -94.4 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.408 3.141 0 CA-C-N 124.697 3.408 . . . . 0.0 112.37 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -114.51 -32.45 5.89 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 40.4 mtp180 -153.93 171.31 19.21 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -101.97 150.79 22.85 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 119.992 -1.693 . . . . 0.0 109.161 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -125.23 121.51 60.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 46.73 -145.01 4.18 Favored Glycine 0 C--N 1.358 1.75 0 C-N-CA 127.133 2.301 . . . . 0.0 118.678 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.0 122.91 47.11 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 126.625 1.97 . . . . 0.0 107.049 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.35 -4.37 62.17 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-O 118.973 -0.904 . . . . 0.0 114.352 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.798 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -129.69 163.11 26.83 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-O 123.602 1.668 . . . . 0.0 112.487 -178.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' C ' HG22 ' A' ' 33' ' ' VAL . 60.7 m-85 -141.21 153.67 45.41 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 127.291 2.237 . . . . 0.0 112.489 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 31' ' ' ARG . 13.6 ttpt -108.12 115.25 29.78 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 100.27 -3.974 . . . . 0.0 100.27 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -133.01 156.24 47.71 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 111.005 -2.816 . . . . 0.0 112.214 -164.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 47' ' ' GLU 0.375 7.1 tt -129.38 146.6 51.22 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 119.38 -2.075 . . . . 0.0 107.295 171.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m-85 -77.44 158.56 29.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 123.313 2.778 . . . . 0.0 111.923 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.78 -1.7 1.48 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.991 2.917 . . . . 0.0 115.021 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -123.35 1.35 9.02 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 130.272 3.429 . . . . 0.0 111.624 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.19 19.71 25.25 Favored Glycine 0 C--N 1.383 3.18 0 N-CA-C 119.99 2.756 . . . . 0.0 119.99 168.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.77 106.77 18.77 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.79 1.795 . . . . 0.0 109.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.1 tt0 -95.45 152.04 18.76 Favored 'General case' 0 C--N 1.362 1.143 0 O-C-N 120.286 -1.509 . . . . 0.0 114.408 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -168.01 178.84 4.91 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' HG21 ' A' ' 33' ' ' VAL . 1.7 m-20 -120.92 137.75 54.45 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 165.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' A' ' 55' ' ' ILE . 16.2 m -148.12 168.3 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 C-N-CA 124.07 0.948 . . . . 0.0 111.193 -174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 1.3 mm? -71.47 148.41 46.85 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.452 1.501 . . . . 0.0 111.613 168.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 54' ' ' ASP . . . -78.14 -44.35 11.83 Favored Glycine 0 C--N 1.368 2.33 0 O-C-N 120.699 -1.25 . . . . 0.0 112.101 -159.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 9.41 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 128.586 2.755 . . . . 0.0 115.599 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 52' ' ' GLY . 77.4 m-20 -119.17 -78.42 0.59 Allowed 'General case' 0 N--CA 1.434 -1.27 1 C-N-CA 135.57 5.548 . . . . 0.0 105.778 173.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.19 101.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 117.027 -3.546 . . . . 0.0 109.984 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 125' ' ' LEU . 4.2 pp -133.97 160.62 37.16 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.0 ' HB2' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -52.8 102.63 0.05 Allowed 'General case' 0 CA--C 1.564 1.498 1 C-N-CA 134.209 5.004 . . . . 0.0 113.523 163.616 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.441 ' SG ' ' CD2' ' A' ' 125' ' ' LEU 0.319 0.5 OUTLIER -122.55 175.43 6.47 Favored 'General case' 0 N--CA 1.406 -2.657 1 C-N-CA 132.053 4.141 . . . . 0.0 106.492 -171.527 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.81 -41.73 1.03 Allowed Pre-proline 0 CA--C 1.561 1.401 0 O-C-N 118.904 -2.373 . . . . 0.0 111.829 168.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.4 Cg_endo -63.4 -74.07 0.0 OUTLIER 'Cis proline' 0 C--N 1.383 2.345 0 CA-C-N 125.311 2.933 . . . . 0.0 115.272 7.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.672 HD12 HD13 ' A' ' 119' ' ' LEU 0.383 0.5 OUTLIER -116.24 160.26 36.47 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-N 120.373 1.442 . . . . 0.0 110.502 -171.732 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' ILE . 85.1 Cg_exo -60.6 125.58 17.69 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 126.806 5.004 . . . . 0.0 113.659 -165.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 ' CE1' ' A' ' 84' ' ' HIS 0.48 1.1 mp -40.45 14.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 2 C-N-CA 136.23 5.812 . . . . 0.0 124.563 -174.271 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.395 7.0 m-20 -153.41 26.4 0.52 Allowed 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 131.845 4.058 . . . . 0.0 110.241 -175.27 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.5 m -115.61 134.53 54.96 Favored 'General case' 0 CA--C 1.453 -2.774 0 CA-C-O 123.779 1.752 . . . . 0.0 114.101 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 87.5 tt0 -61.64 93.67 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 128.244 2.618 . . . . 0.0 112.238 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.53 162.97 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.631 0 O-C-N 118.492 -2.63 . . . . 0.0 108.923 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 t -95.47 134.81 37.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.26 139.03 37.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.539 -0.726 . . . . 0.0 109.75 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 109.89 4.16 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-O 126.577 3.084 . . . . 0.0 118.806 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.8 m -139.48 168.15 20.47 Favored 'General case' 0 N--CA 1.435 -1.178 1 C-N-CA 134.454 5.102 . . . . 0.0 100.744 171.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.3 pm0 -39.49 165.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.794 3.628 . . . . 0.0 120.794 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -44.97 -49.49 11.15 Favored 'General case' 0 N--CA 1.479 1.012 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.06 11.48 23.88 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 125.927 1.691 . . . . 0.0 111.754 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -115.86 -34.5 4.76 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.534 1.534 . . . . 0.0 111.644 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER -53.12 131.17 36.3 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 177.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.7 m -140.26 160.32 40.22 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 112.737 -2.029 . . . . 0.0 111.352 -161.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.346 . . -81.72 153.93 26.3 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 120.925 3.676 . . . . 0.0 120.925 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -152.88 -167.52 15.64 Favored Glycine 0 CA--C 1.481 -2.065 1 N-CA-C 102.446 -4.262 . . . . 0.0 102.446 177.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.69 135.04 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 CA-C-N 120.562 2.181 . . . . 0.0 111.41 -172.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HB ' HG21 ' A' ' 67' ' ' VAL . 12.6 p -77.29 130.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.305 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 159.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -122.23 -36.77 2.91 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.943 0.878 . . . . 0.0 113.24 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.52 145.75 10.85 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 120.509 -1.369 . . . . 0.0 110.59 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.425 ' CE1' HD21 ' A' ' 63' ' ' LEU 0.341 2.3 p80 -147.76 151.97 36.94 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 178.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 169.49 17.51 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.292 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -136.9 148.09 46.83 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 161.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -128.19 161.08 30.14 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -54.88 69.44 0.0 OUTLIER 'General case' 0 C--N 1.354 0.786 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.46 12.08 13.98 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 127.516 2.484 . . . . 0.0 112.066 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -132.69 150.56 52.14 Favored 'General case' 0 C--N 1.366 1.293 0 C-N-CA 125.932 1.693 . . . . 0.0 107.886 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -133.91 129.21 36.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 174.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.483 2.2 p90 -146.08 138.2 25.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 114.157 -3.017 . . . . 0.0 113.01 167.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.08 147.07 27.04 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -95.88 99.11 10.95 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.563 HG13 HG11 ' A' ' 109' ' ' VAL . 47.9 mm -95.97 115.59 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.622 0 C-N-CA 127.839 2.456 . . . . 0.0 108.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -91.33 107.1 18.97 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.284 38.8 tttp -144.21 134.61 24.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -161.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.85 3.35 1.59 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.458 1.903 . . . . 0.0 115.499 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.23 -4.8 17.99 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 127.882 2.658 . . . . 0.0 111.433 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -134.37 167.73 20.2 Favored 'General case' 0 C--N 1.36 1.024 0 O-C-N 121.277 -1.131 . . . . 0.0 112.974 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.384 0.6 OUTLIER -101.5 127.55 48.13 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.209 -2.182 . . . . 0.0 113.753 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -101.27 142.51 32.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.371 1.468 . . . . 0.0 107.513 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -107.86 105.84 15.84 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.3 m-85 -128.23 123.34 33.97 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.341 -171.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 156.01 11.66 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 127.158 2.183 . . . . 0.0 112.496 164.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -31.94 -53.78 0.28 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 120.121 3.378 . . . . 0.0 120.121 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -63.52 -13.32 39.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.583 3.153 . . . . 0.0 115.771 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -91.36 -23.44 20.08 Favored 'General case' 0 C--N 1.383 2.052 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 173.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 95' ' ' ILE 0.266 0.0 OUTLIER -126.68 98.18 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 131.041 3.737 . . . . 0.0 116.402 178.782 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' PHE 0.276 0.2 OUTLIER -111.93 -170.81 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.344 1.858 . . . . 0.0 114.95 -176.38 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 24' ' ' PHE . 1.3 pt? -146.94 158.11 43.83 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 118.413 2.745 . . . . 0.0 118.413 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 t -101.71 175.06 5.68 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 126.378 1.871 . . . . 0.0 111.083 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.508 ' CD2' ' HA2' ' A' ' 22' ' ' GLY 0.608 0.0 OUTLIER -62.4 -31.66 72.37 Favored 'General case' 0 C--N 1.399 2.721 0 O-C-N 118.084 -2.885 . . . . 0.0 116.37 179.371 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.612 4.7 mt-10 -79.29 -10.55 59.84 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 123.865 3.03 . . . . 0.0 117.394 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.94 -41.28 16.06 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.15 1.38 . . . . 0.0 108.313 164.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.03 -50.48 40.19 Favored Glycine 0 C--N 1.357 1.709 0 C-N-CA 127.506 2.479 . . . . 0.0 115.134 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 120' ' ' ARG 0.258 3.8 m120 -76.69 -19.57 57.58 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 119.303 -2.292 . . . . 0.0 114.685 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -30.34 69.46 Favored 'General case' 0 C--N 1.37 1.495 0 O-C-N 120.458 -1.401 . . . . 0.0 111.711 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.672 HD13 HD12 ' A' ' 61' ' ' ILE . 7.6 tt -88.87 -38.52 14.5 Favored 'General case' 0 C--N 1.373 1.606 0 C-N-CA 131.466 3.906 . . . . 0.0 111.307 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 25.6 ptt180 -45.05 -39.25 5.58 Favored 'General case' 0 C--N 1.365 1.253 1 N-CA-C 122.06 4.096 . . . . 0.0 122.06 -165.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.5 -15.5 30.64 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 129.767 3.227 . . . . 0.0 112.631 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . 0.27 17.5 pt20 -105.28 -49.25 3.5 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 125.358 1.463 . . . . 0.0 113.284 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.02 1.31 5.27 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 119.064 2.987 . . . . 0.0 119.064 -170.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.08 -71.42 0.1 Allowed Glycine 0 CA--C 1.464 -3.102 1 C-N-CA 112.382 -4.723 . . . . 0.0 106.913 -162.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.65 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.47 0.2 OUTLIER -50.3 13.32 0.0 OUTLIER 'General case' 0 C--N 1.363 1.16 1 N-CA-C 123.467 4.617 . . . . 0.0 123.467 -171.51 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.95 90.96 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 116.66 -2.685 . . . . 0.0 119.039 162.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -81.95 -5.32 12.18 Favored 'Trans proline' 0 CA--C 1.548 1.212 1 CA-C-N 125.952 4.876 . . . . 0.0 112.732 175.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -117.29 126.98 53.62 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.774 2.43 . . . . 0.0 105.061 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 C--N 1.352 0.712 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -177.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.9 p30 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-O 122.615 1.198 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 m -175.69 -174.79 0.71 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.49 ' H ' ' HB2' ' A' ' 32' ' ' ASP 0.302 8.1 m-30 -92.05 61.4 4.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 122.443 2.383 . . . . 0.0 112.618 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.309 1.6 m -84.54 5.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 130.053 3.341 . . . . 0.0 114.258 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.91 38.59 0.53 Allowed Glycine 0 C--N 1.369 2.378 0 O-C-N 118.209 -2.807 . . . . 0.0 109.733 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.887 HD11 ' HA ' ' A' ' 57' ' ' LEU 0.331 0.3 OUTLIER -96.23 166.91 11.5 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.391 1.567 . . . . 0.0 108.541 176.221 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' H ' HD22 ' A' ' 12' ' ' LEU . 15.6 tpp85 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 129.346 3.059 . . . . 0.0 103.787 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.361 9.2 m -107.92 168.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 125.062 2.363 . . . . 0.0 112.625 -176.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.28 122.71 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 55' ' ' ILE . . . -110.16 107.93 17.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 124.456 1.102 . . . . 0.0 112.418 -164.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.676 ' HG3' ' HA ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -137.22 90.15 2.5 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 126.96 2.104 . . . . 0.0 107.593 -174.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -38.66 35.96 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 117.968 -2.958 . . . . 0.0 117.716 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.7 p -105.05 139.39 39.8 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 p -82.3 106.81 14.48 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 119.883 -1.76 . . . . 0.0 111.587 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -128.85 -30.43 2.26 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 127.035 2.134 . . . . 0.0 110.894 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.56 39.87 3.8 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.503 -163.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.289 4.4 m-30 -133.61 119.87 19.98 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 110.806 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 111' ' ' LEU . 4.1 m-85 -121.24 104.02 9.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' HG22 ' A' ' 110' ' ' ILE . 16.0 m-85 -93.26 -176.89 4.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 128.553 2.741 . . . . 0.0 108.873 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.3 t -105.53 135.22 47.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.028 1.731 . . . . 0.0 111.052 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -138.51 165.26 25.56 Favored Glycine 0 CA--C 1.496 -1.13 0 C-N-CA 125.708 1.623 . . . . 0.0 112.868 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -131.13 142.66 50.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.233 1.413 . . . . 0.0 111.664 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 12' ' ' LEU . 4.4 tt -101.66 155.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.38 1.909 0 O-C-N 118.242 -2.786 . . . . 0.0 114.608 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 m -111.83 -43.92 3.54 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.693 1.197 . . . . 0.0 110.311 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -155.66 171.66 19.61 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 9' ' ' PHE . 31.9 t70 -100.66 134.74 43.18 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.014 -1.679 . . . . 0.0 108.962 172.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG23 ' HB2' ' A' ' 37' ' ' LYS 0.251 0.2 OUTLIER -109.14 125.84 66.22 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.322 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 31.74 -123.67 0.21 Allowed Glycine 0 C--N 1.361 1.924 1 C-N-CA 131.278 4.275 . . . . 0.0 122.67 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.64 111.24 23.87 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 123.366 1.555 . . . . 0.0 110.02 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.15 74.15 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 126.837 2.16 . . . . 0.0 116.332 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.827 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -114.26 165.7 12.41 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.576 1.688 . . . . 0.0 108.478 -179.986 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.63 143.14 32.26 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.732 2.013 . . . . 0.0 106.302 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -110.69 109.88 20.32 Favored 'General case' 0 C--N 1.385 2.114 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.68 166.29 23.26 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 111.461 -2.608 . . . . 0.0 115.952 -162.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.323 8.0 tt -129.06 141.06 51.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 O-C-N 119.975 -1.703 . . . . 0.0 107.314 165.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.8 m-85 -71.65 159.85 33.69 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 117.007 -3.558 . . . . 0.0 107.855 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.56 -7.8 35.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 117.034 -3.541 . . . . 0.0 115.238 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -97.19 -3.81 40.22 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 130.023 3.329 . . . . 0.0 113.499 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 105.12 10.57 31.74 Favored Glycine 0 C--N 1.374 2.692 0 N-CA-C 119.343 2.497 . . . . 0.0 119.343 170.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -91.68 105.81 18.01 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 120.519 2.16 . . . . 0.0 107.803 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -107.68 150.36 27.01 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.799 -1.188 . . . . 0.0 112.059 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 t -170.21 178.48 3.81 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 102.304 -3.221 . . . . 0.0 102.304 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.09 138.66 48.44 Favored 'General case' 0 C--N 1.35 0.601 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 160.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 ' HB ' ' A' ' 55' ' ' ILE . 33.8 m -147.34 166.38 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.165 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -172.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 37' ' ' LYS 0.254 3.9 mm? -79.49 150.96 31.04 Favored 'General case' 0 C--N 1.372 1.572 0 CA-C-O 123.438 1.589 . . . . 0.0 112.581 170.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.7 -42.01 55.25 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 113.29 -1.777 . . . . 0.0 115.103 -153.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 3.96 0.09 Allowed 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 127.684 2.394 . . . . 0.0 115.758 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 71.3 m-20 -116.06 -58.09 2.14 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.122 4.969 . . . . 0.0 107.578 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 40' ' ' LEU 0.299 0.9 OUTLIER -130.85 102.64 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 O-C-N 117.075 -3.515 . . . . 0.0 113.308 174.159 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 125' ' ' LEU 0.442 1.8 pp -134.71 162.62 31.82 Favored 'General case' 0 C--N 1.378 1.817 1 N-CA-C 124.659 5.059 . . . . 0.0 124.659 -168.801 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.887 ' HA ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.34 100.32 0.03 OUTLIER 'General case' 0 C--N 1.383 2.029 0 C-N-CA 130.967 3.707 . . . . 0.0 117.262 170.377 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.252 0.0 OUTLIER -126.56 175.57 7.82 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 111.65 -2.523 . . . . 0.0 113.703 -173.012 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -94.63 -43.49 0.29 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.662 2.785 . . . . 0.0 110.452 166.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 58' ' ' CYS . 19.9 Cg_exo -65.44 -77.55 0.0 OUTLIER 'Cis proline' 0 CA--C 1.484 -1.991 0 CA-C-N 126.626 3.402 . . . . 0.0 116.045 5.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CG1' HD22 ' A' ' 111' ' ' LEU 0.303 0.1 OUTLIER -113.12 159.54 34.44 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 116.732 -1.604 . . . . 0.0 111.644 -168.742 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' HD12 ' A' ' 119' ' ' LEU . 17.5 Cg_exo -53.2 113.55 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.413 1 C-N-CA 125.975 4.45 . . . . 0.0 117.255 -160.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.254 3.4 mt -37.84 14.79 0.0 OUTLIER 'General case' 0 C--N 1.357 0.924 2 C-N-CA 134.593 5.157 . . . . 0.0 124.312 -174.469 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.67 52.03 0.35 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 127.095 2.158 . . . . 0.0 105.37 170.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 m -115.69 131.19 57.01 Favored 'General case' 0 CA--C 1.44 -3.282 0 C-N-CA 127.705 2.402 . . . . 0.0 110.797 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 29.2 tp10 -61.9 94.73 0.05 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.593 1.957 . . . . 0.0 111.623 164.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.657 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.0 OUTLIER -114.63 172.53 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.051 1 C-N-CA 135.764 5.626 . . . . 0.0 106.357 -179.677 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.482 HG23 ' CD1' ' A' ' 110' ' ' ILE 0.319 11.5 t -107.2 148.34 29.01 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.772 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.88 124.26 52.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.95 116.69 23.5 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 8.9 m -137.34 169.05 18.44 Favored 'General case' 0 N--CA 1.439 -1.018 1 C-N-CA 136.226 5.811 . . . . 0.0 101.917 178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.1 pm0 -39.27 168.27 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 130.859 3.664 . . . . 0.0 120.765 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -49.41 -50.22 41.5 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 121.571 3.915 . . . . 0.0 121.571 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -110.59 11.16 22.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 126.133 1.773 . . . . 0.0 112.074 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -110.97 -34.33 6.25 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.319 1.448 . . . . 0.0 111.481 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -54.12 144.88 18.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 118.211 2.671 . . . . 0.0 118.211 175.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.6 p -140.57 162.31 35.66 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.463 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.352 . . -97.11 145.98 25.47 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-O 123.099 1.428 . . . . 0.0 113.479 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' GLU . . . -149.83 -167.78 14.51 Favored Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 103.58 -3.808 . . . . 0.0 103.58 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -111.9 136.26 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 O-C-N 119.751 -2.029 . . . . 0.0 111.569 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 67' ' ' VAL . 7.6 p -77.19 132.44 32.81 Favored 'Isoleucine or valine' 0 C--N 1.365 1.259 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 163.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -124.06 -34.06 3.02 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.79 1.306 . . . . 0.0 112.815 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.67 153.57 20.2 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 120.454 -1.404 . . . . 0.0 111.62 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 59' ' ' ASP 0.304 0.8 OUTLIER -150.2 153.58 36.5 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.17 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.42 156.86 45.23 Favored 'General case' 0 C--N 1.372 1.574 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -173.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -137.85 141.68 40.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.1 160.87 30.66 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -63.44 79.87 0.03 OUTLIER 'General case' 0 C--N 1.365 1.279 0 O-C-N 119.455 -2.028 . . . . 0.0 115.074 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.77 3.11 23.73 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 126.688 2.089 . . . . 0.0 113.832 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -131.47 137.35 48.55 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.26 124.71 27.84 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 102.368 -3.197 . . . . 0.0 102.368 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . 0.397 3.5 p90 -146.07 132.3 19.47 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.061 -3.056 . . . . 0.0 112.05 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 95' ' ' ILE . 2.2 m-30 -105.55 137.24 43.72 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.827 -2.656 . . . . 0.0 103.827 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 p -92.88 98.77 11.59 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.531 HG13 HG21 ' A' ' 109' ' ' VAL . 42.5 mm -102.45 118.46 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 CA-C-N 113.36 -1.745 . . . . 0.0 107.444 -172.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.7 104.26 16.38 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-O 121.344 0.592 . . . . 0.0 109.769 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -144.0 128.62 18.14 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.58 -167.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 76.6 3.85 3.5 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.146 2.578 . . . . 0.0 110.188 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.14 -14.23 33.75 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 128.143 2.783 . . . . 0.0 111.853 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -114.18 163.42 15.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.22 1.408 . . . . 0.0 112.163 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.5 mmt-85 -90.28 123.96 34.49 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 120.23 -1.544 . . . . 0.0 112.747 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.03 119.84 39.45 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -91.1 104.14 16.75 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 7.0 m-85 -121.8 125.61 46.92 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-N 111.632 -2.531 . . . . 0.0 106.851 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -63.38 172.73 1.84 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 126.359 1.864 . . . . 0.0 113.938 168.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 107' ' ' MET 0.295 2.3 ptt-85 -30.55 -63.82 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.807 3.643 . . . . 0.0 119.613 -177.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.463 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 23.2 ptm -74.02 -6.94 50.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.907 2.883 . . . . 0.0 114.004 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 104' ' ' TYR . . . -96.1 -15.63 22.05 Favored 'General case' 0 C--N 1.389 2.289 0 O-C-N 120.344 -1.473 . . . . 0.0 114.369 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.531 HG21 HG13 ' A' ' 95' ' ' ILE 0.506 0.0 OUTLIER -126.25 112.07 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 C-N-CA 127.989 2.516 . . . . 0.0 114.704 179.026 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -132.98 179.44 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 112.171 -2.286 . . . . 0.0 114.713 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.79 HD11 ' CD2' ' A' ' 24' ' ' PHE . 4.2 pp -136.35 170.75 15.53 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.457 1.903 . . . . 0.0 109.557 173.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.6 t -111.4 175.31 5.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.079 -1.638 . . . . 0.0 112.062 171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.294 0.9 OUTLIER -79.81 -6.11 56.71 Favored 'General case' 0 CA--C 1.461 -2.445 0 O-C-N 117.693 -3.129 . . . . 0.0 118.095 -174.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.39 11.0 tt0 -78.39 -25.28 46.12 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.408 1.099 . . . . 0.0 112.561 164.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.657 HE22 ' HA ' ' A' ' 67' ' ' VAL . 75.1 mt-30 -82.58 -36.09 26.52 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 166.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.1 -50.8 61.58 Favored Glycine 0 C--N 1.37 2.44 0 O-C-N 118.917 -2.364 . . . . 0.0 112.441 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.49 -8.94 57.99 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.902 1.681 . . . . 0.0 113.825 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -50.6 19.56 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-O 123.529 1.633 . . . . 0.0 108.737 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 125' ' ' LEU . 5.3 tt -86.13 -32.87 21.07 Favored 'General case' 0 CA--C 1.471 -2.068 1 C-N-CA 132.331 4.252 . . . . 0.0 111.305 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -44.05 -35.88 2.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 120.643 3.572 . . . . 0.0 120.643 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -89.14 -23.2 22.52 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.426 2.29 . . . . 0.0 113.361 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -104.08 -44.26 5.05 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.859 2.064 . . . . 0.0 113.994 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -130.63 6.81 4.78 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 117.657 2.466 . . . . 0.0 117.657 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.91 -68.73 0.19 Allowed Glycine 0 CA--C 1.46 -3.372 0 CA-C-N 125.106 3.594 . . . . 0.0 105.835 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.612 ' HA ' HD21 ' A' ' 56' ' ' LEU 0.524 0.3 OUTLIER -48.47 13.59 0.0 OUTLIER 'General case' 0 C--N 1.374 1.646 1 N-CA-C 122.309 4.188 . . . . 0.0 122.309 -160.576 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.14 92.83 0.09 OUTLIER Glycine 0 C--N 1.347 1.169 0 N-CA-C 120.495 2.958 . . . . 0.0 120.495 160.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -82.64 -8.95 11.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 1 CA-C-N 125.603 4.701 . . . . 0.0 112.539 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -117.74 148.95 41.54 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 127.956 2.503 . . . . 0.0 109.015 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.361 1.105 0 C-N-CA 125.958 1.703 . . . . 0.0 112.936 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 p -82.12 -21.24 36.78 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 128.633 2.773 . . . . 0.0 113.924 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.83 -27.16 14.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.588 1.555 . . . . 0.0 113.285 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 10' ' ' VAL . 71.5 t -51.12 -17.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 130.508 3.523 . . . . 0.0 119.65 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.15 36.51 1.8 Allowed Glycine 0 C--N 1.346 1.089 0 C-N-CA 125.334 1.445 . . . . 0.0 111.777 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 57' ' ' LEU . 4.3 tp -78.94 167.13 21.57 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 128.602 2.761 . . . . 0.0 110.945 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -105.71 133.95 49.62 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.466 3.9 m -126.29 152.82 34.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.018 0 O-C-N 119.53 -1.981 . . . . 0.0 114.272 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 125' ' ' LEU . 3.0 m -117.32 142.13 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 C-N-CA 127.291 2.236 . . . . 0.0 106.609 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 55' ' ' ILE . . . -116.58 106.91 14.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 124.749 2.214 . . . . 0.0 113.939 -164.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.568 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -137.5 93.76 2.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 126.268 1.827 . . . . 0.0 107.652 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -71.39 -56.35 6.14 Favored 'General case' 0 C--N 1.37 1.485 0 O-C-N 118.775 -2.453 . . . . 0.0 111.84 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 p -115.71 134.31 55.16 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -66.59 110.22 3.1 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 127.032 2.133 . . . . 0.0 112.464 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -97.17 -20.85 17.67 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.61 -18.43 29.74 Favored Glycine 0 CA--C 1.488 -1.594 0 CA-C-O 117.487 -1.73 . . . . 0.0 109.501 -161.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.407 1.2 p90 -137.16 158.12 45.16 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 120.243 2.021 . . . . 0.0 115.64 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.709 ' CD2' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -118.2 148.97 41.86 Favored 'General case' 0 C--N 1.37 1.46 0 C-N-CA 127.708 2.403 . . . . 0.0 108.99 175.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.18 -175.42 3.67 Favored 'General case' 0 C--N 1.362 1.129 1 C-N-CA 133.882 4.873 . . . . 0.0 108.489 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.6 t -125.42 148.68 48.71 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 117.785 -3.072 . . . . 0.0 118.612 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 42' ' ' PHE . . . -138.92 166.74 25.32 Favored Glycine 0 C--N 1.362 2.025 1 C-N-CA 133.463 5.316 . . . . 0.0 118.392 -171.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB3' HH22 ' A' ' 106' ' ' ARG . 53.0 pttt -135.43 137.0 41.81 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.439 2.295 . . . . 0.0 111.786 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.802 HG21 HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -107.12 147.75 12.05 Favored 'Isoleucine or valine' 0 C--N 1.367 1.334 0 O-C-N 118.121 -2.862 . . . . 0.0 111.873 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -111.61 -38.73 4.82 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.571 2.348 . . . . 0.0 112.631 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -143.37 155.69 44.49 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.22 128.17 42.89 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 120.514 -1.366 . . . . 0.0 108.962 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -106.5 136.62 40.51 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 32.43 -133.53 0.2 Allowed Glycine 0 C--N 1.367 2.262 1 C-N-CA 130.727 4.013 . . . . 0.0 122.541 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.38 111.75 24.59 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.331 1.453 . . . . 0.0 108.62 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.6 9.78 86.75 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 125.831 1.681 . . . . 0.0 116.104 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.865 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.373 1.4 pttt -107.15 164.04 12.5 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 120.254 2.027 . . . . 0.0 112.465 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -137.93 135.42 36.04 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 128.369 2.668 . . . . 0.0 109.406 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -108.22 103.05 12.15 Favored 'General case' 0 C--N 1.39 2.347 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -135.23 165.82 24.54 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 111.316 -2.675 . . . . 0.0 115.807 -159.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.338 6.5 tt -129.39 152.1 49.31 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 119.835 -1.79 . . . . 0.0 108.162 170.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 3.0 m-30 -72.42 168.91 17.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 118.014 -2.929 . . . . 0.0 111.943 175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.5 -5.24 18.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 117.766 -3.084 . . . . 0.0 113.218 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -125.31 15.27 8.34 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.052 2.541 . . . . 0.0 115.128 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 103.21 5.03 47.04 Favored Glycine 0 C--N 1.378 2.897 0 N-CA-C 120.893 3.117 . . . . 0.0 120.893 165.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -92.53 105.42 17.59 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 120.278 2.039 . . . . 0.0 109.992 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 40' ' ' LEU 0.252 25.9 tt0 -97.53 150.75 20.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.26 177.95 6.55 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.307 1.8 m-20 -124.66 137.17 54.38 Favored 'General case' 0 C--N 1.356 0.886 1 N-CA-C 99.923 -4.103 . . . . 0.0 99.923 164.771 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' HB ' ' A' ' 55' ' ' ILE . 11.1 m -148.24 161.8 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.431 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -82.59 133.51 35.18 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 124.762 1.225 . . . . 0.0 109.695 171.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' HD13 ' A' ' 51' ' ' LEU . . . -67.42 -32.56 79.54 Favored Glycine 0 C--O 1.205 -1.672 0 C-N-CA 125.638 1.589 . . . . 0.0 115.457 -148.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.37 8.64 0.03 OUTLIER 'General case' 0 CA--C 1.586 2.347 0 CA-C-N 121.365 2.583 . . . . 0.0 116.282 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -115.83 -73.13 0.66 Allowed 'General case' 0 N--CA 1.436 -1.166 1 C-N-CA 133.954 4.902 . . . . 0.0 108.828 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.515 ' HB ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -118.46 101.4 11.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 O-C-N 117.653 -3.154 . . . . 0.0 107.605 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.749 HD22 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.59 159.0 42.99 Favored 'General case' 0 CA--C 1.484 -1.575 1 N-CA-C 123.889 4.774 . . . . 0.0 123.889 -164.036 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.814 ' CB ' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.95 102.8 0.05 OUTLIER 'General case' 0 C--N 1.379 1.853 1 C-N-CA 132.404 4.282 . . . . 0.0 117.36 171.255 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 60' ' ' PRO 0.299 0.1 OUTLIER -125.22 175.55 7.34 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 129.364 3.065 . . . . 0.0 106.43 -177.472 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -43.94 1.31 Allowed Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 131.406 3.883 . . . . 0.0 108.126 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 10.9 Cg_endo -57.18 -75.29 0.0 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.846 0 CA-C-N 123.989 2.46 . . . . 0.0 117.654 0.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 HD23 ' A' ' 111' ' ' LEU . 3.1 mm -117.05 155.43 49.46 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 119.644 1.111 . . . . 0.0 113.044 -161.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' CD ' HD12 ' A' ' 119' ' ' LEU . 71.7 Cg_exo -54.01 119.18 5.87 Favored 'Trans proline' 0 C--N 1.374 1.889 1 C-N-CA 129.155 6.57 . . . . 0.0 115.078 -171.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' H ' HD12 ' A' ' 63' ' ' LEU 0.334 4.9 mp -40.86 14.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 2 C-N-CA 138.519 6.728 . . . . 0.0 123.561 -179.38 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.4 14.8 m-20 -138.69 14.88 2.72 Favored 'General case' 0 C--N 1.309 -1.187 1 C-N-CA 135.216 5.406 . . . . 0.0 112.0 -175.32 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 97.5 m -115.31 117.11 29.53 Favored 'General case' 0 CA--C 1.437 -3.382 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -160.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -64.66 93.95 0.11 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.517 1.927 . . . . 0.0 109.343 163.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.5 173.45 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.464 -2.351 1 C-N-CA 135.538 5.535 . . . . 0.0 104.205 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.287 1.7 t -94.61 147.19 23.54 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 118.266 -1.374 . . . . 0.0 110.614 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.13 138.38 42.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.27 114.66 26.05 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-O 122.944 1.354 . . . . 0.0 113.395 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -137.95 167.51 21.61 Favored 'General case' 0 N--CA 1.445 -0.684 1 C-N-CA 134.083 4.953 . . . . 0.0 102.491 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.2 pm0 -39.53 171.66 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 121.65 3.944 . . . . 0.0 121.65 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -47.9 -49.44 29.88 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 121.782 3.993 . . . . 0.0 121.782 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -109.9 12.02 23.98 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 125.852 1.661 . . . . 0.0 111.015 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -118.22 -31.14 5.09 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 125.838 1.655 . . . . 0.0 111.747 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.307 0.2 OUTLIER -53.61 127.03 23.89 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 173.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 t -141.62 163.04 33.99 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.07 -164.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.34 . . -86.33 142.53 28.43 Favored 'General case' 0 C--N 1.365 1.264 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.18 168.3 30.77 Favored Glycine 0 C--N 1.363 2.079 0 N-CA-C 105.991 -2.844 . . . . 0.0 105.991 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.95 119.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.4 124.35 26.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 O-C-N 120.51 -1.369 . . . . 0.0 108.016 169.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.52 -27.09 2.2 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.95 136.81 4.23 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 93' ' ' TYR . 4.5 p-80 -146.72 153.58 40.42 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 153.8 51.08 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 125.18 1.392 . . . . 0.0 107.857 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -136.81 124.52 22.44 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 162.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -123.23 160.43 26.61 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 126.117 1.767 . . . . 0.0 107.129 -175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.1 m -62.84 65.21 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.068 2.547 . . . . 0.0 116.867 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.02 13.8 8.24 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 127.453 2.454 . . . . 0.0 113.178 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.53 135.61 35.23 Favored 'General case' 0 C--N 1.368 1.396 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.0 126.59 44.56 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 119.951 -1.718 . . . . 0.0 106.952 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.418 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 60.4 m-85 -144.37 114.89 7.63 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 116.343 -2.143 . . . . 0.0 114.542 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 8.3 m-85 -110.25 114.4 27.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 126.672 1.989 . . . . 0.0 105.782 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.476 ' HB3' ' CE3' ' A' ' 103' ' ' TRP . 98.3 p -87.67 108.34 19.05 Favored 'General case' 0 C--N 1.377 1.801 0 C-N-CA 127.306 2.242 . . . . 0.0 108.548 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.7 mm -110.0 120.8 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 -172.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.65 111.55 21.4 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 120.796 -1.19 . . . . 0.0 110.896 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.253 39.4 tptt -143.35 129.74 19.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.952 -165.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 68.54 3.28 3.75 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.953 2.101 . . . . 0.0 113.966 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.45 -7.24 16.12 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.204 2.335 . . . . 0.0 111.451 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -130.0 164.93 23.21 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.631 1.172 . . . . 0.0 112.239 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.314 0.1 OUTLIER -92.45 124.88 36.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 119.873 -1.767 . . . . 0.0 113.555 -177.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -96.87 118.15 32.67 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 94' ' ' SER . 73.8 m95 -97.17 104.76 16.81 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -107.63 153.04 23.48 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 124.151 0.981 . . . . 0.0 108.563 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -81.94 137.77 35.1 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 161.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 28' ' ' LYS . 68.9 mtm180 -31.2 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 121.477 3.88 . . . . 0.0 121.477 -167.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -66.86 -13.92 62.15 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 127.629 2.371 . . . . 0.0 116.0 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.47 9.96 39.26 Favored 'General case' 0 C--N 1.38 1.897 0 O-C-N 120.01 -1.681 . . . . 0.0 114.134 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.84 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -132.98 -176.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 120.358 -1.464 . . . . 0.0 109.817 176.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.769 HD23 HG13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -148.13 151.02 34.89 Favored 'General case' 0 C--N 1.364 1.232 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 94.3 p -87.1 170.43 11.53 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.959 3.304 . . . . 0.0 110.285 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . 0.406 0.5 OUTLIER -66.29 -41.7 89.42 Favored 'General case' 0 C--N 1.383 2.037 0 O-C-N 118.583 -2.573 . . . . 0.0 114.882 174.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.659 33.9 mt-10 -68.58 -10.36 55.4 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.18 -46.89 19.31 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 129.106 2.963 . . . . 0.0 108.919 162.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 24' ' ' PHE . . . -73.87 -47.47 19.61 Favored Glycine 0 C--N 1.353 1.528 0 C-N-CA 130.29 3.805 . . . . 0.0 118.518 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 7.1 m120 -77.93 -25.28 48.22 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 130.835 3.654 . . . . 0.0 113.045 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 119' ' ' LEU . 4.1 ptm180 -67.1 -32.83 74.24 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-O 122.453 1.12 . . . . 0.0 110.841 172.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.589 HD13 HD13 ' A' ' 61' ' ' ILE . 7.1 tt -82.46 -39.83 22.0 Favored 'General case' 0 CA--C 1.481 -1.704 1 C-N-CA 133.19 4.596 . . . . 0.0 110.891 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.3 ptm180 -48.88 -26.62 2.55 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 120.896 3.665 . . . . 0.0 120.896 -166.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -94.09 -29.43 15.18 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 130.598 3.559 . . . . 0.0 113.138 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -101.78 -43.36 5.86 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 126.992 2.117 . . . . 0.0 115.243 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -131.06 6.19 4.56 Favored 'General case' 0 C--N 1.375 1.712 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.38 -76.9 0.1 OUTLIER Glycine 0 CA--C 1.458 -3.509 1 C-N-CA 112.769 -4.539 . . . . 0.0 106.919 -165.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.749 HD13 HD22 ' A' ' 56' ' ' LEU 0.539 1.4 mm? -49.05 13.7 0.0 OUTLIER 'General case' 0 C--N 1.374 1.671 1 N-CA-C 122.897 4.406 . . . . 0.0 122.897 -163.865 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.66 100.81 0.15 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-O 116.312 -2.382 . . . . 0.0 113.933 163.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -83.75 -27.09 1.78 Allowed 'Trans proline' 0 CA--C 1.551 1.36 1 CA-C-N 126.925 5.362 . . . . 0.0 111.71 173.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -117.51 113.77 22.49 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 131.058 3.743 . . . . 0.0 103.839 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.353 0.75 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -175.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 p -104.25 20.67 17.94 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 125.604 1.562 . . . . 0.0 111.157 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 57' ' ' LEU . 54.9 m-85 -106.69 19.73 20.06 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 127.017 2.127 . . . . 0.0 112.678 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.28 -45.62 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.244 2.618 . . . . 0.0 114.851 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.19 52.37 0.64 Allowed Glycine 0 C--N 1.375 2.698 0 O-C-N 118.575 -2.578 . . . . 0.0 111.108 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -106.09 166.12 10.73 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-O 124.103 1.906 . . . . 0.0 109.43 176.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -109.33 142.53 40.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 127.479 2.312 . . . . 0.0 105.638 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG23 ' HA3' ' A' ' 27' ' ' GLY 0.349 19.4 m -137.44 161.67 33.96 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 121.499 1.954 . . . . 0.0 110.433 -173.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 60' ' ' PRO . 3.6 m -136.22 143.23 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 O-C-N 119.276 -2.14 . . . . 0.0 107.897 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.16 107.15 17.66 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 24' ' ' PHE . 2.6 mtpt -108.54 124.85 51.1 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.607 1.963 . . . . 0.0 106.356 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . 0.306 95.8 m95 -92.29 -90.42 0.18 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 125.164 3.62 . . . . 0.0 113.711 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 m -109.62 150.27 28.46 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -58.43 108.0 0.57 Allowed 'General case' 0 C--N 1.372 1.561 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -170.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -117.26 -22.57 8.23 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 127.795 2.438 . . . . 0.0 109.827 -170.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.01 -17.66 51.73 Favored Glycine 0 CA--C 1.487 -1.663 0 C-N-CA 126.455 1.979 . . . . 0.0 113.432 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER 0.424 0.5 OUTLIER -135.54 154.84 51.24 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.686 2.243 . . . . 0.0 114.243 174.118 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 111' ' ' LEU 0.254 0.0 OUTLIER -117.62 139.99 50.25 Favored 'General case' 0 C--N 1.378 1.809 0 C-N-CA 129.29 3.036 . . . . 0.0 109.662 -176.781 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -99.04 -175.83 3.15 Favored 'General case' 0 C--N 1.358 0.945 1 C-N-CA 132.194 4.198 . . . . 0.0 110.699 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.8 t -77.33 143.04 39.06 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.676 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -139.83 162.41 26.28 Favored Glycine 0 C--N 1.361 1.938 0 CA-C-O 122.654 1.141 . . . . 0.0 115.466 162.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -142.44 143.85 32.8 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.674 2.79 . . . . 0.0 107.189 167.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 12' ' ' LEU . 4.9 tt -95.19 155.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 O-C-N 117.791 -3.068 . . . . 0.0 117.121 -173.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -110.99 -50.09 2.97 Favored 'General case' 0 C--N 1.359 0.983 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -156.78 172.84 17.91 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -90.66 160.01 16.1 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 119.402 -2.061 . . . . 0.0 110.165 167.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -120.12 122.61 68.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 173.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 23.63 -117.63 0.02 OUTLIER Glycine 0 N--CA 1.486 2.01 0 C-N-CA 130.256 3.789 . . . . 0.0 121.985 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.58 122.53 46.49 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 128.457 2.703 . . . . 0.0 110.008 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.7 -11.15 67.27 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 125.688 1.613 . . . . 0.0 114.43 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' HG23 ' A' ' 33' ' ' VAL 0.375 0.7 OUTLIER -114.49 160.69 18.92 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 124.33 2.014 . . . . 0.0 115.391 -173.718 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -135.33 140.23 44.92 Favored 'General case' 0 C--N 1.37 1.499 0 C-N-CA 128.898 2.879 . . . . 0.0 108.962 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -113.54 110.08 19.68 Favored 'General case' 0 C--N 1.379 1.883 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.765 HD23 HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -134.27 161.51 34.76 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 110.866 -2.879 . . . . 0.0 116.019 -162.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.42 HD21 ' HA2' ' A' ' 45' ' ' GLY 0.334 8.1 tt -129.08 149.98 50.67 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 120.223 -1.548 . . . . 0.0 107.869 170.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . 5.2 m-30 -81.98 157.65 24.15 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 116.997 -3.565 . . . . 0.0 109.305 177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.12 -5.6 7.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 117.998 -2.939 . . . . 0.0 114.836 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -106.14 -3.27 21.65 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 130.116 3.366 . . . . 0.0 113.233 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . 99.8 13.98 35.75 Favored Glycine 0 C--N 1.382 3.122 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -99.24 107.88 20.3 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 119.698 1.749 . . . . 0.0 108.903 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -102.96 160.18 14.84 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 t -164.86 178.89 6.85 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . 0.288 1.6 m-20 -119.24 131.89 55.86 Favored 'General case' 0 CA--C 1.506 -0.749 1 N-CA-C 98.869 -4.493 . . . . 0.0 98.869 162.778 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.86 167.2 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 CA-C-N 119.27 0.941 . . . . 0.0 110.497 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -81.22 140.68 34.77 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.97 2.108 . . . . 0.0 110.479 175.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.645 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -85.35 7.65 74.91 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 119.756 -1.84 . . . . 0.0 113.944 -156.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 3.1 49.76 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 118.857 -2.555 . . . . 0.0 107.575 167.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -110.94 -85.75 0.55 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.623 3.569 . . . . 0.0 107.424 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.765 HG21 HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.42 105.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 118.682 -2.511 . . . . 0.0 111.136 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -134.14 162.13 32.97 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 121.638 3.94 . . . . 0.0 121.638 -170.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.596 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -48.88 102.44 0.03 OUTLIER 'General case' 0 C--N 1.381 1.959 1 C-N-CA 133.241 4.617 . . . . 0.0 115.501 169.494 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 60' ' ' PRO 0.257 0.5 OUTLIER -104.57 172.45 6.79 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 125.34 2.495 . . . . 0.0 111.141 -169.054 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.07 -46.02 0.21 Allowed Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 131.046 3.738 . . . . 0.0 107.994 165.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HB3' HG11 ' A' ' 15' ' ' VAL . 14.5 Cg_exo -72.21 -68.64 0.03 OUTLIER 'Cis proline' 0 CA--C 1.487 -1.869 0 CA-C-N 126.36 3.307 . . . . 0.0 114.106 8.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.833 HD12 HD13 ' A' ' 119' ' ' LEU 0.284 0.2 OUTLIER -109.26 159.13 32.43 Favored Pre-proline 0 N--CA 1.434 -1.242 0 C-N-CA 125.807 1.643 . . . . 0.0 108.76 -178.876 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 61' ' ' ILE . 85.8 Cg_exo -63.59 134.91 46.54 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 126.608 4.872 . . . . 0.0 115.543 -163.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.597 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.2 mp -50.22 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.144 2 C-N-CA 136.426 5.891 . . . . 0.0 122.782 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.443 28.6 m-20 -129.72 10.48 5.58 Favored 'General case' 0 C--N 1.303 -1.415 1 C-N-CA 133.616 4.767 . . . . 0.0 111.87 -177.946 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.269 30.6 m -116.31 119.62 36.28 Favored 'General case' 0 CA--C 1.437 -3.37 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -157.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.28 95.49 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-O 123.81 1.767 . . . . 0.0 112.71 164.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.881 ' HA ' HE22 ' A' ' 115' ' ' GLN . 0.1 OUTLIER -97.8 170.88 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.198 1 C-N-CA 132.541 4.337 . . . . 0.0 106.04 -179.292 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.67 141.02 37.84 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 118.394 -1.322 . . . . 0.0 108.103 -171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.36 139.41 40.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.867 -1.145 . . . . 0.0 109.222 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 109.23 2.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 t -139.06 168.58 19.53 Favored 'General case' 0 N--CA 1.447 -0.585 2 C-N-CA 135.307 5.443 . . . . 0.0 100.153 170.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 1.3 pm0 -39.66 165.12 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -44.94 -49.47 11.08 Favored 'General case' 0 N--CA 1.48 1.063 1 N-CA-C 122.64 4.311 . . . . 0.0 122.64 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -111.04 10.93 22.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 126.211 1.804 . . . . 0.0 111.861 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.08 -32.16 5.81 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.488 1.515 . . . . 0.0 111.719 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.251 0.2 OUTLIER -53.21 138.15 32.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.6 m -140.44 160.71 39.39 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.454 -163.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . 0.292 . . -82.52 158.91 22.96 Favored 'General case' 0 C--N 1.359 1.012 1 N-CA-C 122.778 4.362 . . . . 0.0 122.778 -170.014 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.95 163.16 32.15 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 130.509 3.909 . . . . 0.0 103.59 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.33 118.98 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.835 0 CA-C-N 119.721 1.761 . . . . 0.0 112.738 -168.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.48 135.17 28.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -135.28 -31.67 0.97 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 125.52 1.762 . . . . 0.0 113.886 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.61 133.58 3.7 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.375 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 93' ' ' TYR . 2.0 p80 -142.18 147.84 37.25 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 -173.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HD2' ' CD1' ' A' ' 92' ' ' TYR . 7.6 ptp180 -126.26 165.69 18.49 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 126.079 1.752 . . . . 0.0 108.677 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.42 146.94 42.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 108.635 160.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -128.23 160.83 30.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 p -72.39 72.8 0.98 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 119.166 -2.209 . . . . 0.0 114.918 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.28 7.91 13.7 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.653 2.073 . . . . 0.0 113.629 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.57 149.18 47.94 Favored 'General case' 0 C--N 1.367 1.363 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' HG ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -133.37 135.49 44.74 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 -175.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -144.87 139.09 27.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 113.762 -3.175 . . . . 0.0 107.818 169.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 84' ' ' HIS 0.434 48.7 p90 -149.68 165.89 31.01 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 124.325 2.012 . . . . 0.0 114.733 163.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.4 t -105.08 126.94 52.62 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 110.94 -2.846 . . . . 0.0 111.647 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -122.7 127.58 74.97 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -97.14 107.26 19.74 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -144.27 140.68 29.36 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 119.882 -1.761 . . . . 0.0 115.559 -164.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 65.32 3.7 2.38 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 127.036 2.134 . . . . 0.0 114.098 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 120.04 -7.76 11.72 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 127.814 2.626 . . . . 0.0 111.717 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.56 170.81 15.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 O-C-N 121.437 -1.037 . . . . 0.0 113.202 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -89.81 138.5 31.43 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.417 -2.052 . . . . 0.0 113.401 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 43.7 m-85 -130.34 176.17 8.34 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.169 2.188 . . . . 0.0 111.122 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 164.38 12.72 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 98.733 -4.543 . . . . 0.0 98.733 163.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.444 HH12 ' HG ' ' A' ' 111' ' ' LEU . 5.7 mmm180 -32.45 -46.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.944 3.313 . . . . 0.0 119.944 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 22.5 ptm -65.32 -15.33 62.42 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . . . -104.75 -11.78 16.66 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 95' ' ' ILE . 6.8 p -126.12 94.7 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.4 2.28 . . . . 0.0 112.892 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.24 177.34 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 127.518 2.327 . . . . 0.0 114.145 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -146.26 154.47 41.75 Favored 'General case' 0 C--N 1.374 1.633 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 78.0 p -105.55 169.41 8.48 Favored 'General case' 0 C--N 1.365 1.263 0 O-C-N 119.895 -1.753 . . . . 0.0 113.748 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HA ' ' HZ ' ' A' ' 24' ' ' PHE 0.345 4.8 mt -60.82 -48.9 79.7 Favored 'General case' 0 C--N 1.388 2.274 0 O-C-N 119.128 -2.232 . . . . 0.0 115.748 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . 0.855 11.6 mt-10 -66.45 -10.37 43.48 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 125.758 3.89 . . . . 0.0 119.664 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.881 HE22 ' HA ' ' A' ' 67' ' ' VAL . 24.8 mt-30 -86.12 -33.08 20.99 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 128.315 2.646 . . . . 0.0 110.877 162.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 61' ' ' ILE . . . -75.76 -53.46 5.86 Favored Glycine 0 C--N 1.356 1.652 1 C-N-CA 131.361 4.315 . . . . 0.0 115.083 175.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -69.7 -27.17 64.77 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 131.002 3.721 . . . . 0.0 113.635 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -31.6 68.89 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 124.701 1.2 . . . . 0.0 110.872 175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 61' ' ' ILE . 6.7 tt -87.19 -48.25 8.2 Favored 'General case' 0 C--N 1.372 1.552 1 C-N-CA 132.403 4.281 . . . . 0.0 111.334 177.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -35.65 -44.17 0.31 Allowed 'General case' 0 C--N 1.355 0.817 0 N-CA-C 119.927 3.306 . . . . 0.0 119.927 -166.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.52 -17.49 30.16 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.287 2.235 . . . . 0.0 114.268 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.23 -45.43 5.62 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 126.435 1.894 . . . . 0.0 112.107 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.71 -17.22 6.95 Favored 'General case' 0 C--N 1.382 1.997 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -179.51 -59.11 0.08 OUTLIER Glycine 0 CA--C 1.461 -3.342 0 CA-C-N 125.54 3.791 . . . . 0.0 104.851 -173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 56' ' ' LEU 0.622 1.1 mm? -48.62 2.25 0.01 OUTLIER 'General case' 0 C--N 1.38 1.934 0 N-CA-C 120.532 3.53 . . . . 0.0 120.532 -160.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.54 98.52 0.11 Allowed Glycine 0 C--N 1.363 2.058 0 CA-C-O 116.038 -2.534 . . . . 0.0 118.39 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.31 -5.49 15.04 Favored 'Trans proline' 0 C--N 1.381 2.238 1 CA-C-N 127.569 5.684 . . . . 0.0 113.345 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -117.17 131.33 56.9 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 124.762 1.225 . . . . 0.0 107.867 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.353 0.755 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.588 . . . . . . . . 0 0 . 1 stop_ save_